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~DSTR1I.CT
Liver glutaminase, a mitochondrial enzyme, is known to be
activated by hormones such as glucagon. Diabetes mellitus is
a metabolic disease which is characterized by alterations in
the insulin:glucagon ratio and, therefore, represents an in
Y.iY2. situation in which to study the effects of
hyperglucagonemla on liver glutaminase. Glutaminase flux was
found to be increased in isolated hepatocytes and in isolated
mitochondria from streptozotocin-!nduced diabetic rats.
An important question is how the hormonal signal is
transmitted into the mitochondria. One possibility examined
is whether cAMP-mediated phosphorylation of cytosol ic proteins
can stimUlate a mitochondrial enzyme. This was examined using
the cell-permeable protein phosphatase inhibitors okadaic acid
and calyculin A. In the presence of 1 mM NH~Cl, an obligatory
positive effector for liver glutaminase, both inhibitors
increased glutaminase flux in isolated hepatocytes. This
effect was stable, existing in mitochondria isolated from
okadaic acid-treated hepatocytes. The protein kinase A
agonist, Sp-cAMPS, was also found to stimulate glutaminase
flux in isolated hepatocytes. This stimulation was inhibited
by the protein kinase A antagonist, Rp-cAMPS. These results
suggest that the cAMP-dependent phosphorylation of cytosolic
protein(s) can affect mitochondrial glutamine metabolism.
ii
This may also give insight into the mechanisms whereby
hormones, such as glucagon, stimulate mitochondrial glutamine
metabolism.
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Chapt.er 1
Intro4uction
INTRODUCTION
Glutamine is a nonessential amino acid ....ith several
functions in mammalian systems. Ie. is the most abundant amino
acid in blood at a concentration of 0.5 to 0.6 mM (Brosnan ~
AL., 1983). Glutamine serves in the biosynthesis of purines,
pyrimidines, glucosamine, and NAD. In liver it is a precursor
for glucose and for urea; in kidney it is a precursor for
glucose and ammonia. Glutamine synthesis serves to protect
the brain against ammonia toxicity and glutamine can act as a
precursor for certain neurotransmitters. Cells such as
enterocytes, lymphocytes, reticulocytes, oocytes, and cancer
cells use glutamine as a respiratory fuel.
GLUTAMINASE
History
In 1935 Krebs first discovered that extracts of mammiJlian
brain, liver, and kidney could cause deamidation of glutamine
(Krebs, 1935). Using differences in kinetics, he also
identified two different glutaminase activities (liver- and
kidney-type). In the 1940's, further studies by Errera and
Greenstein showed that the activity called glutaminase I was
activated by inorganic phosphate .. l1d that this enzyme was
located within the mitochondria (Errera and Greenstein, 1949).
sUbsequently, Guha (1962) was able to show that liver
glutaminase was exclusively found in mitochondria. Further
studies were conducted to determine the location of
glutaminase within the mitochondria. Using sonication or the
addition of detergents, Kalra and Brosnan (1973) found that
glutaminase was released from liver mitochondria to the same
extent as matrix marker enzymes. From this they concluded
that liver glutaminase was located in the mitochondrial
matrix:. McGivan and co-workers used liver mitochondria
disrupted by freezing and thawing and found that glutaminase
was associated with the mitochondrial membrane fraction
(McGivan g.t.~, 1980). Using intact pig renal mitochondria,
Kvamme n A.L. (1991) suggested that glutaminase has a
predominantly external localization on the inner mitochondrial
membrane. Their conclusion was taken from experiments in
which sulfhydryl, (SH), reagents which may not penetrate the
inner mitochondrial membrane still caused an inhibition of
glutaminase. However, this location is not generally accepted
since there are difficulties with the permeablity of SH
reagents and their re(\ctivity with transporters involved in
glutamine metabolism.
General properties
Glutaminase (L-glutamine amidohydrolaSej (EC 3.5.1.2) is
also known as glutaminase I, phosphate-activated glutaminase,
and phosphate-dependent glut... ,inase.
following irreversible reaction:
It catalyses the
The activity originally described as glutaminase II 1s
actually a combination of glutamine-oxo-acid amidotransferase
and &I-amidase. It consists of the following two reactions:
glutamine + a-ketoglutaratez• .. 2-oxoglutaramate· + glutamate
and
2-oxoglutaramate- + H20'" o:-ketoglutarateZ- + NH4'
with a net reaction of:
L-glutamine + H20'" L-glutamate + NH,'
Glutaminase will be used in this thesis to represent the
EC 3.5.1.2 enzyme. There are, however, two isoenzymes of
glutaminase. This was first demonstrated by Krebs in 1935
(Krebs, 1935).
Kidney-type glutaminase
Kidney-type glutaminase is found in kidney, brain,
intestine, skeletal muscle, heart and lung. It is also found
in fetal liver, tumours, lymphocytes, and reticulocytes. This
isoenzyme of glutaminase is activated by phosphate (Errera and
Greenstein, 1949) and is inhibited by glutamate. The
inhibition by glutamate is noncompetitive with glutamine but
is competitive with phosphate (Sayre and Roberts, 1958). The
J<m for glutamine is 4 to 5 roM for the kidney enzyme (Klingman
and Handler, 1958), 2 to 8 mM for the brain enzyme (Svenneby
n aL., 1973) and 2.2 mM for the intestinal enzyme (pinkus and
windmueller, 1977).
Other compounds can also affect kidney-type glutaminase.
This glutaminase can be activated by ATP, ADP, rTP, CTP, and
some carboxylic acids such as succinate, cr-ketoglutarate and
malate (see Kovacevic and MCGivan, 1983). sulfhydryl (SH)-
blocking reagents such mercuric chloride, p-
chloromercuribenzoate (PCMB), mersalyl, N-ethylmaleimide, and
3,3' -dithiobis[ 6-nitro-]benzoic actd (DTNB) inhibit the
kidney-type enzyme (Kvamme gt SlL., 1970).
In the kidney, glutaminase activity increases during
metabolic acidosis (Curthoys tl~, 1976) and streptozotocin-
induced diabetes (Watford §.t al,., 1984). It is also increased
by feeding diets high in protein (Brosnan g A.L.., 1978). If
the acidosis associated with these situations is corrected by
NaHCo, administration, the glutaminase activity does not
increase (Brosnan gt. aL.., 1978; Watford §..t. M..,., 1984).
Liver type-glutaminase
Liver-type glutaminase is found only in adult liver. It
is not inhibited by glutamate (Krebs, 1935) as is the case for
kidney-type glutaminase. However, like the kidney-type
glutaminase, the liver-type is inhibited by SH-blocking agents
(Joseph and Meijer, 1981). smith and Watford (1988, 1990)
have been able to purify and characterize rat liver-type
glutaminase. They report an apparent subunit molecular mass
of 58,000 Da with a Km for glutamine of 17 mM and a pH optimum
of 7.8 to 8.2 (Smith and Watford, 1988).
Intercellular glutamine cycling and ammonia detoxirication
The functional units of the liver are the so-called
acini. An acinus represents a cluster of parenchymal cells
which are grouped about terminal branches of the hepatic
arteriole and portal venule (Lautt and Greenway, 1987). The
vascular stalk enters the center of the acinus '.lIhere the
hepatic arterial and portal venous blood are well mixed within
the periportal zone. All entrances to the acinus occur in the
periportal region, while all exits occur at the periphery.
The acini extend from the terminal portal venule to the
terminal hepatic venule. The cells near the portal venule are
referred to as the periportal hepatocytes. These periportal
hepatocytes are supplied with blood that is rich in oxygen,
hormones and substrates. The smaller group of cells, known as
perivenous hepatocytes, are located near the hepatic venule.
This perivenous zone is supplied by blood which is poor in
oxygen but rich in carbon dioxide and metabolic products.
Immunohistochemical studies indicate that carbamoyl-
phosphate synthetase I (Gaasbeck-Janzen n AL.., 1984) and
glutamine synthetase (Gebhardt and Mecke, 1983) are localized
exclusively in the periportal and perivenous area of the liver
lobule, respectively. using the perfused rat liver,
Haussinger has been able to demonstrate the importance of
hepatocyte heterogeneity in glutamine and ammonia metabolism
(Haussinger, 1983). This work has suggested a role of an
intercellular glutamine cycle during ureagenesis in perfused
rat liver.
Haussinger's studies involved perfusing rat liver in the
physiological antegrade (portal to caval vein) and in
retrograde (caval to portal vein). He found that added
ammonium ions at low concentrations are mainly converted to
urea in antegrade perfusion and to glutamine in retrograde
perfusions (Haussinger, 1983). These studies support the
concept of cellular heterogeneity in liver. Further evidence
of this is provided by the observation that when perivenous
hepatocytes are selectively destroyed by a dose of CCl" the
livers fail to synthesize glutamine and to take up glutamate
(Hiiussinger n Al......, 1983; Gebhardt n S!..L.., 1988).
The organization of the liver cells and of the enzymes
involved in ammonia detoxification is physiologically
important-. The portal blood first comes into contact with
hepatocytes capable of urea synthesis before glutamine-
synthesizing cells in the perivenous zone are reached. The
rate-limiting enzyme of the ur~a cycle is carbamoyl-phosphate
synthetase. It has an higher Km for total a .....,onia (NH] and
NH/l than does glutamine synthetase (Cohen g.t AL... 1985).
Therefore, it may be said that the periportal zone represents
low-affinity, high capacity system for ammonia
detoxification compared to the high-affinity perivenous zone
(Haussinger, 1990). Ammonia at a physiological portal
concentration of 0.2 to O. J mM is converted by about two-
thirds into urea and one-third into glutamine (Haussinger,
1990) .
Hepatic Transport of Glutamine
Glutamine is transported into hepatocytes by a Na·-
uef,lendent transport system. Kilberg II AL..(19BOl first
described this system and named it system N. In addition to
glutamine, this system also transports asparagine and
histidine. A lOO-kDa plasma membrane protein may mediate
system N transport in rat hepatocyt.es (Tamarappoo n Al....,
1992). Glutamine can also ",e transported via system A,
although this transport is est .... r,iated to represent only 5 to 10
% of total hepatic glutamine transport (LoW .!It. SlL., 1991).
Na·-independent transport of glutamine is involved in efflux
of glutamine from perivenous hepatocytes (Fafournoux n Sll......,
1983; Burger gt 4L., 1989).
System N transport of -Jlutamine is not affected by
glucagon or insulin in short term hepatocyte incubations
(Kilberg §.t Al....., 1980) but induction does occur with l:lrolonged
exposure of cell cultures to hormones (Gebhardt and Kleeman,
1987). corticosteroid treatment of rats was found to increase
system N activity in liver sinusoidal membrane vesicles (Low
n Al.... 1992). streptozotocin-indtlced diabetes causes an
increase in system N activity in isolated hepatocytes (Barber
n ll...... 1982) !:Jut this was not found in sinusoidal membrane
vesicles (Low ~.ill......, 1992). Decreasing the extracellular pH
also causes a decrease in glutamine uptake in perfused rat
liver (Lenzen g,.t B..l......, 1987).
System N activity is high in liver. This is indicated by
the fact that portal blood glutamine is at 0.6 roM while the
liver tissue concentration is 4 to 6 mM. Haussinger has found
that histidine in near-physiological concentrations inhibits
both glutamine uptake by periportal hepatocytes anti its
release by perivenous hepatocytes (Hiiussinger II AL.., 1985).
This suggests that glutamine transport can be involved in the
regulation of hepatic glutamine metabolism.
Glutamine catabolism occurs in mitochondria mainly
through the actions of glutaminase. Glutamine has been shown
to equilibrate rapidly across the inner mitochondrial membrane
(Joseph and MCGivan, 1978b; Joseph and Meijer, 1981). This is
due to a specific carrier which can be inhibited by mersalyl
(Joseph and Meijer, Hal). In contrast, Soboll n sU...... (1991)
have also suggested that glutamine uptake into mitochondria is
an electroneutral event which is sensitive to changes in pH.
This study involved incubating isolated mitochondria with a
known concentration of [I4C]glutamine and then determining
glutamine uptake by measuring both the radioactivity
associated with the mitochondrial pellet and the glutamine
concentration in the medium. From this they concluded that
increasing pH causes an increase in glutamine uptake. ~nother
study by the same group had previously shown that when the pH
increases from 7.3 to 7.7 the mitochondrial concentration
increases from 15 to 50 mM (Lenz'oln n AL.., 1987). These
values were obtained by fractionating freeze-clamped liver
tissue in non-aqueous solvents and SUbsequently determining
the glutamine concentration in the various fractions. This,
in my mind, does not represent an accurate method for
determining intracellular glutamine concentrations and may
account for the high values obtained.
It is, of course, possible that transport of glutamine
across the plasma membrane or across the inner mitochondrial
membrane could be rate-limit . \n the overall metabolism of
glutamine. This has been examl......d from the point of view of
control strength (Pogson tl Al.,., 1990; Low ~ AL., 1990).
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These studies used L-glutamate-y-hydrazide to inhibit
glutaminase in isolated hepatocytes and in isolated
mi tochondria. At the concentrations tested, there was no
effec:. of this compound on glutamine transport processes (Low
~ AL., 1990). The degree of inhibition of glutamine
metabolism in hepatocytes and mitochondria was essentially the
same at a given concentration of L-glutamate-y-hydrazide. The
flux control coefficent eKerted by glutaminase was, therefore,
equal to 1.0 (Pogson ,gt~, 1990) suggesting that transport
processes were not rate limiting. Repeating these eKperiments
using isolated hepatocytes in the presence of histidine showed
that the flux control coefficent of glutamine uptake by system
N was 0.31, and therefore as previously stated by HaUSf".nger
fl..t. AL.. (1985), trar'Iport across the plasma membrane could
eKQrt a regulatory influence on glutamine metabolism (Pogson
n £L., 1990).
REGULATION OF LIVER-TYPE GLUTAMINASE
Activators ot liver-type glutaminase
Liver glutaminase has an interesting property in being
activated by one of its products, namely arnmon~a. This was
first reported for intact liver mitochondria (Charles, 1968)
and has subsequently been ohserved in isolated perfused rat
liver (Haussinger n al...., 1983) and hepatocytes (Joseph and
McGivan, 1978a). Ammonia stimulation of glutaminase is found
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in mitoChondria that have been disrupted by freezing and
thawing (Joseph and McGivan, 1978b; Verhoeven §.t .AL.., 1983:
Szweda and Atkinson, 1989). This indicates that ammonia acts
directly on the enzyme.
The exact role of bicarbonate in regulating liver
glutaminase is still uncertain. contradictory reports have
bicarbonate either activating or having no effect on liver
glutaminaze. In isolated mitochondria (Joseph and McGivan,
1975b), and in isolated hepatocytes (Saverel and Lund, 1979)
bicarbonate is reported to act as an activator of glutaminase.
In mitochondria di~rupted by freezing and thawing, HCO}'
activated glutaminase by decreasing the half-maximal phosphate
requirement without affecting the maximal velocity of the
enzyme (MCGivan II a.L,., 1980). In the absence of HCOl ' or
NH4C1, glutaminase assayed in freeze-thawed mitochondria
required 25 mM pi for half-maximal activity while in tho
presence of HCO}' or NH4C1 this pi requirement was reduced to
4mM (McGivan n AL., 1980). Using a semi-purified glutaminase
preparation, Patel and McGivan (1984) were not able to shaw a
stimulation by HC03·. However in t: e isolated perfused rat
liver, glut~...inase was not affected by the presence of HCO)'
in the perfusat.e (HaUssinger .!!t ~, 1980). It can therefore
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be said that the role of bicarbonate in regulating liver
glutaminase is still uncertain.
Several other substances have been found to affect liver-
type glutaminase. In isolated hepatocytes, Baverel and Lund
(1979) found that leucine at near-physiological concentrations
(0.1-1 pM) is an activator 0-: glutaminase. In intact liver
mitochondria EOTA stimulates glutaminase and this activation
can be reversed by low concentrations of MgC12 (Joseph n Al....
1981) . The addition of EDTA affected glutaminase by
decreasing the concentration of phosphate required for half-
maximal stimulation. They interpreted this to mean that Mgz+
actually inhibits glutaminase and its removal by EOT~ reverses
this inhibition. Using freete-thawed disrupted mitochondria.
glutaminase was not affected by EDTA or MgClz (Joseph n ll.....
1981; McGivan tl S!..L.., 1985). EDTA and EGTA have been reported
to have stimulatory effects on membrane bound glutaminase
(Szwt<da and Atkinson, 1990b). This report also indicates that
glutaminase is stimulated by a rise in Mg2+ concentration.
again due to an increase in the apparent affinity of the
enzyme for the positive modifier phosphate (Szweda and
Atkinson. 1990b). They also found that increasing the citrate
concentration stimulated glutaminasp.; by increasing the
13
affinity of the enzyme for glutamine (Szwcda and Atkim..on,
1990b) .
In disrupted mitochondria, the NH4CI stimulation was
increased by the addition of ATP (Joseph and MCGivan, 1978b).
This was also observed for the HC03- stimulation of glutaminase
(Joseph and McGivan, 19'/l3b). In the absence of ·•• .-l,Cl and HC03-
, ATP caused a lowering of the phosphate concentration
required for half-maximal activation of glutaminase (McGivan
§.t aL.., 1980).
N-acetylglutamate is an esst:!ntial activator of carbamoyl-
phosphate synthetase. It was also shown by Blackburn g.t. AL.
(1972) that 5 rnM N-acetylglutamate stimulates glutaminase in
isolated rat liver mitochondria after a lag of 10 minutes.
Similar results using intact mitochondria have been claimed by
Meijer and Verhoeven (1986). In this study, however, they
proposed to manipulate N-acetylglutamate levels only by
inCUbating mitochondria with glutamate and did not actually
measure the N-acetylglutamate levels. These investigators
were also unable to show an activation by N-acetYlglutamate ir.
broken mitochondria. using purified glutaminase, Smith and
\'latford (1988) showed that N-acetylglutamate activated
glutaminase by about 10\. These results seem to indicnte that
14
N-acetylglutamate has little, or no, affect on liver
glutaminase.
In liver, ureagenesis is stimulated by an increase in pH
which leads to removal of bicarbonate and its role has
recently been seen in preventing alkalosis, as well as
rElmoving the toxic amnlonia, thus preventing hyperammonemia.
Liver glutaminase has been shown to be sensitive to changes in
pH, being stimulated by an alkaline pH (Haussinger tl i!J....a.,
1983; Snodgrass and Lund, 19R4; Szweda and Atkinson, 1989).
The rise in pH stimulates glutaminase by increasing the
affinity of the enzyme for glutamine with no effect on the
maximal rate (Snodgrass and Lund, 1984; Szweda and Atkinson,
1989) . The increase in glutaminase activity du.s: to
increasing pH may also be mediated· by increases in the
affinity of the enzyme for its positive modifiers, ammonia and
phosphate (Szweda and Atkinson, 1989). This is shown by the
observation that the concentration of NH,+ required for half-
maximal rates decreases as pH increases (Szweda and Atkinson,
1990a) .
Hormonal regt:.lation of liver-type glutaminase
Liver glutaminase has been demonstrated to be regUlated
by hormones. In isolated hepatocytes, Joseph and McGivan
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(1978a) showed that glucagon stimulated gluconeogenesis from
glutamine to a far greater extent than from any other amino
acid precursor. They also found that glucagon caused a
decrease in intracellular glutamine and an increase in
glutamate. This was attributed to an activation of
glutaninase by glucagon. Verhoeven n lli (1985) found an a-
adrenergic stimulation of glutamine metabolism in isolated rat
hepatocytes. Later, Vincent n lli (1989) were also able to
demonstr-te an increase in glutaminase flux in isolated
hepatocytes due to added vasopressin. Using perfused rat
liver, Haussinger gt .e.L. (1983) found that glutaminase flux
was increased by ammonium ions or glucagon with the eHects
being additive.
Liver mitochondria isolated from rats injected with
glucagon have been shown to have altered metabolism compared
to control mitochondria from saline-injected rats.
Mitochondria froln glucagon-injected rats have higher rates of
pyruvate carboxylation and decarboxylation (Adam and Haynes,
1969; Garrison and Haynes, 1975), citrulline synthesis
(Yamazaki and Graetz, 1977; Hengsens ~ ill.:.., 1980), and
glycine oxidation (Jois fi~, 1989) compared to mitochondria
from saline-injected controls. Lacey tllli (1981) also found
that injecting rats with glucagon caused an increased
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effective activity of glutaminase in subsequently isolated
liver mitochondria. This glucagon effect was seen to decrease
the requirement of glutaminase for phosphate. The effect was
also lost on disruption of the mitochondria which suggests
that the integrity of the mitochondrial membrane is important
for the glucagon effect (Lacey n li...., 1981).
Hormonal effects on mitochondrial metabolism have also
been found using mitochondria isolated from hepatocytes
previously incubated with hormones. This was first
demonstrated by Siess and Wieland (1979) when they showed
increased succinate dehydrogenase activity in mitochondria
from glucagon-incubated and dibutyryl cAMP-incubated
hepatocytes. Covera and Garcia-Sainz (1983) found that by
incubating hepatocytes for 10 minutes with hormones and then
isolating mitochondria, glutaminase flux was increased in the
isolated mitochondria. This was observed for adrenaline,
vasopressin, al"'Jiotensin II, and glu~agon.
In the above studies there were no steps taken to
preserve t~e phosphorylation state of the proteins in the
isolated mitochondria. The mitochondria, once isolated, were
seen to somehow "retain" the stimulatory effect of the added
hormone. This raises the question of exactly how the hormonal
signal gets transmitted into the mitochondria and how does it
17
affect mitochondrial enzymes such as glutaminase. Several
ideas have been put forth to answer this question. Halestrap·
(1989) has cited increases in mitochondrial volurnes as playing
a role in the hormonal signalling process. Such honnonal
increases in volume may be caused by a ca2+-mediated increase
in the electrogenic K'" entry. Calcium may cause this by
increasing the matrix concentration of ppi (pyrophosphate) by
inhibiting the matri>= pyrophosphatase. The increased ppi then
displaces ADP or ATP that is blocking a K+ channel (Ha1estrap,
1989). Lacey n .eL. (1981) also found that incubating
mitochondria in hypoosmotic medium produced the same effects
as isolating mitochondria from glucagon-injected rats. other
investigators have found that liver mitochondria isolated from
glucagon-injected rats do not have increased volume (Wingrove
II .5!.L., 1984; Jois II AL.., 1992). The involvement of
mitochondrial volume c~anges in hormo:'lal signalling therefore
remains uncertain.
A second proposal suggests that glucagon application
stabilizes rather than activates mitochondrial functions.
siess n AL. (1981) proposed that mitochondria from 9lllcagon-
injected rats are better able to withstand the isolation
procedurG than are mitochondria from control, saline-injected
rats. This view has been opposed by Jensen nlli (1983) who
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found that even in crude liver homogenates glucagon treatment
caused increases in such processes as carboxylation of
pyruvate and citrulline synthesis. Unlike the earlier study,
the choice of mitochondrial isolation medium was without
effect. Allan gt AL. (1983) also found that hormonal effects
persisted in mitochondria located in permeable filfpin-treated
hepatocytes. Also similar effects were found in hepatocytes
and isolated mitochondria.
Many cytoplasmic events be affected by
phosphorylation processes caused by the action of hormones.
There is no direct evidence using llP-labelled hepatocytes that
glucagon causes an increase in the phosphorylation of a
mitochondrial membrane protein(s) (Siess and wieland, 19791
Vargas n S!l....., 1982). This does not necessarily mean that
phosphorylation/dephosphorylation of cytoso1ic protein(s) is
not involved in the overall signalling process. It is
certainly possible that such cytosolic events can have effects
on mitochondrial functions.
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DIABETES MELLITUS AND HEPATIC GLUTAMINE CATABOLISM
The term "diabetes mellitus" is used to represent a
number of disease states in which hyperglycemia is the most
constant metabolic abnormality. From an endocrinological
viewpoint, diabetes mellitus is caused by impaired actions of
insulin either due to impaired secretion or end-orgal"
unresponsiveness, and to hypersecretion hyper
responsiveness to the actions of counter-regulatory hormones
such as glucagon, growth hormone, and catecholamines.
Relative hyperglucagonemla is present in all forms of diabetes
in which glucose production exceeds glucose disposal ami thus
results in "endogenous hyperglycemia" (Unger and orcl, 1981).
Such glucagon excess causes the hepatic abnormalities of
severe diabetes including increased glycogenolysis, increased
gluconeogenesis, and increased ketogenesis. This only occurs
if the countering actions of insulin are deficient.
Diabetes mellitus results in increased muscle proteolysis
which provides amino acid substrates for gluconeogenesis.
There is also an increased production of urea by the liver.
The involvement of a hyperglucagonemic state in incroased urea
production has been demonstrated in a recent study (Almdal n
aL.., 1992). In this study, one group of streptozotocin-
induced diabetic rats was injected with a specific antibody
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against pancreatic glucagon \lhile a second group of diabetic,s
received an injection of noniJ:lllune rabbit seruCl. Urea
synthesis \las i '.creased 2.5 told in the serum treated
diabetics \lhile the production in the glucagon antibody
treated-diabetics was identical to the non-diabetic controls
(Almdal s.t AL.., 1992). This lends support for the importance
of glucagon in causing changes in hepatic amine acid
metabolism in diabetes.
Glutamine is an important glucogenle amino acid in the
liver. In the normal physiological state, there is no
significant uptake or release of glutamine by the liver
(Brosnan .f:..t AL.., 1983). This chang8i; to a net uptake of
glutamine in diabetes mellitus (SChrock and Goldstein, 1981;
Brosnan II sl.... 1983). Such an increase in uptake suggests an
increased metabollsa of glutamine associated with diabetes
mellitus.
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AGONISTS/ANTAGONISTS USED IN HORMONAL SIGNALLING STUDIES
Okadaic acid and CIllycu1in A
Okadaic acid, (C44"66013)' is a complex fatty acid
po1yketa1 produced by dinoflagellates (Figure 1.1). It
accumulates in the digestive glands of shellfish and marine
sponges. One such marine sponge, Halichondria 2MQ.ill, was
the first to be used in the isolation of okadaic acid and
accounts for the origins of its name (Tachibana II al., 1981).
Okadaic acid has been found to cause diarrhetic seafood
poisoning. This toxin accumulates in the midgut glands of
bivalves feeding on dinoflagellates. Although okadaic acid
caused such poisoning, the mechanism of its action was
unknown. Takai and co-workers, using isolated vascular smooth
muscle, discovered that okadaic acid was a potent inhibitor of
protein phosphatase 1 (PP1) and protein phosphatase 211. (PP2A)
(Takai ,g"t. li....., :a5a7). These arc two of the four major protein
phosphatases, in the cytosol of mammalian cells, which
dephosphorylate serine and threonine residues (Cohen and
Cohen, 1989). The actions of okadaic acid are illustrated in
Figure 1.2.
Ca1yculir. A contains an octamethy1 polyhydroxy1ated C28
fatty acid which is linked to two -amino acids and esterfied
by phosphoric acid (Figure 1.1). It was first isolated from
22
Fiqure 1.1 structures ot' the phosphatase inhibitors 0)(::),4aic
acid and calyculin l\
C).~.y--",. ~:::ox..
"l).", JY'.-{Y y ~ ~
Okadaic Acid
" )=,~~"... , o· !",....-..,.~.A.Jl.-.~" ,,s'>- -
A:' :. ;-{,.",' l
calyculin A
Fiqure 1.2. :Illustration showing how the phosphatase
inhibitors okaelaie aciel anel ealyeulin A increase tho
phosphorylation levels of proteins.
Stimuli, such as cAMP, working through protein kinasQs cause
the phosphorylation of threonine and serine residues on
proteins. Phosphatases remove the phosphate group from the
threonine and serine residues. Okadaic acid and calyculin A
increase the level of phosphorylation by inhibiting this
removal.
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a marino spongQ, piscodermia ~, and is a strong inhibitor
of starfish development and has po....erful toxic effects on
Ll210 leukemia cells (suganuma II itL., 1990). calyculin A,
like okadaic acid, inhibits protein phosphatase 1 and 2A
(Ishihara ll~, 1989) and is cell permeable (Cohen n AL.,
1990). Its actions are also given in Figurl! 1.2.
Protoin Phosphatase and Okadaic Acid
Cohen and. Cohen (1989) classify four major classes of
protein phosphatase (PP) catalytic subunits. These are
subdivided into type 1 and type 2 with three! subtypes of type
2. Type I phosphatase, PPl, dephosphorylates the B-subunit of
phosphorylase kinase specifically. It is also inhibited by
nanomolar concentrations of the thermostable proteins
l'lhibitor-l and inhibitor-2. This phosphatase does not have
an absolute requirement for divalent cations. Type 2
phosphatases, PP2, dephosphorylate the a-subunit of
phosphorylase kinase preferentially and are unaffected by the
inhibitors. Protein phosphatase 2A, PP2A, like PPI does not
require divalent cations. Protein phosphatase 2B and 2C are
Caz+/calmodulin- and Mgz,_ dependent, respectiv",ly. PP2A is
completely inhibited by 1 nM okadaic acid, while PPI requires
higher concentrations of 10-15 nM of okadaic acid (Cohen !!.t
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aL., 1990). The phosphatase inhibitor calyculin A completely
inhibits PP2A and PP1 at a concentration of 1 nM (Ishihara II
AL.., 1989).
Mitochondrial pyruvate dehydrogenase phosphatase, protein
phosphatases that deph"sphorylate tyrosine residues, acid and
alkaline phosphatases, and hlOsitol trisphosphatase are all
insensitive to okadaic acid (Haystead §.t sL... 1989; Cohen gt
aL., 1990). There was also no inhibition of eight different
protein kinases tested (Cohen gt iU......, 1990). using 32p_
labelled hepatocytes. the addition of okadaic acid stimulated
the overall levels of protein phosphorylation by 2.5 to 3-
fold (Haystead gj; AL... 1989; Cohen gt AL,., 1990). Proteins
whose phosphorylation increased included rate-limiting enzymes
of glycogen and lipid metabolism, glycogenolysis and
gluconeogenesis. This included cytosolic enzymes such as
acetyl CoA carboxylase, ATP-citrate lyase, pyruvate kinase,
and 6-phosphofructo-2 -kinase/ fructose-2, 6-bisphosphatase
(PFK2/FBPase) (Haystead ll.aL., 1989). Glycogen phosphorylase
and glycogen synthase in the hepatocyte glycogen fraction wet.,)
also phosphorylated. No increase in protein phosphorylation
was observed in the microsomal fraction (Haystead .!it ~,
1989). In this particular study, the mitochondrial fraction
was not examined.
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In intact calls, namely adipocytes and hepatocytes,
higher concentrations of the phosphatase inhibitors are needed
than those employed in Yitl;:Q. In most studies the eff9cts of
okadaic acid on intact cells were maximal at 1 ,uM (Haystead §.t
AL., 19&9: Cohen n.aL., 1990; Hardie tl ilL.., 1991). There
are two probable reasons for this. The first is even though
okadaic acid and calyculin A are hydrophobic and can penetrate
cell membranes, a higher concentration may be needed in the
medium to ensure that enough inhibitor gets into the cytosol.
A second explanation is that a concentration of 1 I.lM is
necessary becau3e the intracellular concentrations of PPI and
PP2A lie in the range of 0.1-1 pM (Haystead tl a.L., 1989;
Hardie ll.!lL., 1991).
Use of Okadaic Acid in Isolated Cells
Okadalc acid has been used exten.. .i. vely in the study of
metabolic regulation in isolated hepatocytes and adipocytes.
In hepatocytes, okadaic acid mimicked the action of glucagon
by increasing glucose output and conversion of lactate to
glucose (Haystead II AL.., 1989). Okadaic acid also stimu1al..:es
carnitine palmitoyltransferase I activity and palmitate
oxidation in isolated rat hepatocytes (Guzman and Castro,
1991). In isolated adipocytes, okadaic acid stimulated basal
2.
Figure 1. 3 structures of tbe cAMP analogues SpRcAMPS and Rp-
cAMPS
Rp-cAMPS Sp-cAMPS
lipolysis and inhibited acetyl c.:oA carboxylase, the rate-
limiting enzyme in fatty acid biosynthesis (Haystead II u....,
1989). Okadaic acid also stimulated 2-deoxyglucoso uptake by
adipocytes (Haystead n AL., 1989: Lawerence tl Al...., 1990;
Covera II AL., 1991). However, okadaic acid inhibited
insulin-stimulated glucose transport into adipocytes
(Lawerence ll~, 1990: Covera ll~, 1991). All of these
studies indicate that okadaic acid is cell-permeable and
phosphorylation / dephosphorylation events play major roles in
metabolic regulation. It remains to be established if
n:itochondrial enzymes su ...:h as glutaminase can be affected by
cytosolic protein phosphorylation/dephosphorylation events.
cA.."IP analogutls an4 hormonal signalling
cAMP has poor cell permeability when used 'Hith isolated
cells but there are a number of analogues of cAMP which have
better cell permeability and, depending their
stereOChemistry, act as either agonist or antagonist towards
protein kinase A. Cyclic adenosine-J', 5' -mon0l'hosphothiorate,
cAMPS, is an analogue of the natural signal molecule cAMP in
which one of the two exocyclic oxygen atoms in the cyclic
phosphatase moiety is replaced by sulphur. Equatorial thio
substitution leads to the R-isomer, while axial modification
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yields the S-compound. The structures are given in Figure
1.3. Sp-cAMPS acts as an agonist and Rp-cAMPS as an
antagonist towards protein kinase A. The Sp-isomer binds to
the holoenzyme of protein kinase A with approximately 10\ of
the binding affinity of cAMP but fully activates the protein
kinase (Rothermel ll.5!..l......, 1983). Binding of the Sp-isomer
still allows for the release of the active catalytic subunit
from protein kinase A. Rp-cAMPS also binds to the holoenz}:ne
but the Rp-cAMPS-holoenzyme complex does not dissociate to
release the free catalytic subunit (Rothermel ~ 2L.. 1983).
Both isomers are very stable against cyclic nucleotide
phosphodiesterases (van Haastert and Kien, 1983).
Sp-cAMPS and Rp-cAMPS have been used 1n studies inVOlving
isolated hepatocytes (Rothermel ll~, 1983; Rothermel .!it
aL.. 1984; Connelly ~ £h, 1987). Sp-cAMPS stimulates
gl~ .:ogenolysis in isolated hepatocytes and this stimulation is
inhibited by Rp-cAMPS l!tothermel ~ aL.. 1983). Rp-cAMPS has
also been used to inhibit glucagon-induced increases in
glycogenolysis in isolated hepatocytes (Rothertrlel II AL.,
1984; Botelho n AL.. 1988). This indicates that both cAMPS
isomers can be used in probing hormonal signalling events in
isolated hepatocytes.
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SUMMARY OF TOPICS COVERED
The areas of research covered in this thesis can be
divided into two sections. The first section deals with
diabetes mellitus and hepatic glutamine catabolism, while the
second section covers hormonal regulation and signalling with
respect to hepatic glutaminase.
Diabetes represents a physiological situation in which
the endogenous circulating glucagon levels are increased and
provides a situation where the effects of glucagon on hepatic
glutamine catabolism can be studied. Therefore, the possible
effects of diabetes mellitus on glutaminase flux in isolated
hepatocytes and in isolated liver mitochondria from
streptozotocin-induced diabetic rats were studied. If
diabetes does result in an increase in glutaminase flux, there
is still the question of whether or not insulin treatment of
the diabetic rats would prevent or reduce such an increase.
This may lend further support for the hormonal regulation of
glutaminase. A second question is whether such a stimulation
in diabetes is due to more enzyme (smith and Watford, 1988) or
to activation of the enzyme, or to a combination of the two.
As previously stated, hepatic glutaminase is known to be
under hormonal control. The maj or unanswered question is how
the hormonal signal gets into the mitochondria and how does it
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affect mitochondrial enzymes such as glutaminase. In the
second section of this thesis this problem is examined using
various cell-permeable agonists and antagonists.
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CHA2TER 2
MATERIALS AND METHODS
MATERIALS
Chemicals
collagenase A was obtained from Boehringer Mannheim
(Montreal, Quebec). Okadaic acid and calyculin A were
supplied by Biomol Research Laboratories, Plymouth Meeting,
PA. Rp- and Sp- cAMPS were purchased from Biolog Life Science
Institute, La Jolla, CA. Protamine zinc insulin (beef and
pork PZI) was from Eli Lilly Company (Toronto, Ontario). [1-
14C)Glutamate, and Omnifluor were from DuPont New England
Nuclear (Mississauga, ontario). QAE sephadex 1\,-25 was from
Pharmacia LKB, Baie D'urfe, Quebec. Glucagon, epinephrine and
streptozotocin were from Sigma (st. Louis, USA). All other
chemicals were obtained from sigma and were of the highest
grade possible.
preparatio'D. of [l_14C] glutamine
To prepare [1_14c ]glutamine from (1_ 14C]glutamate, a
15,000 x 9 supernatant from a rat liver homogenate of 1 part
tissue plus 3 parts 0.9' NaCI was used as a crude preparation
of glutamine synthetase. The incubation was for 3 hours at
37° C. The incubation mixture gave a final volume of 0.5 ml
and consisted of: Tris/HCl buffer, pH 7.4 (78 roM); NH4Cl (15.6
roM); MgCl z (15.6 roM); ATP (7.8 roM); L-(I-14C)glutamate (5.6
3S
mM); phosphocreatine (7.8 mM); creatine kinase (10 units/ml)
and crude enzyme (0.2 ml/ml) (Saverel and Lund, 1979). The
reaction mixture was deproteinized with 0.05 ml of 10\
perchloric acid (w/v). The pH was then adjusted to 7.0 using
50\ (w/v) K2C03 • [1_HC]Glutamine was separated from any {l-
14c ]glutamate by column chromatography using sephadex QAE.
This is an anion exchanger which will bind glutamate but not
glutamine. This gel had been equilibrated with Tris-HCl (40
mM) pH 5.7 and the carrier medium was 10 111M Tris-HCI, pH 5.7
(Haussinger n AL.., 1983). Thin layer chromatography was then
used to determine if any glutamate was present in the [1_14C)
glutamine preparation. The sample containing a known amount
of radioactivity was spotted on the plate along with glutamine
and glutamate standards. The plate was developed in n-
propanol:concentrated ammonia (7:3 v/v). Spots were located
by spraying with ninhydrin spray (0.2% in ethanol) and the
sample was compared to the glutamine and glutamate standards
as to the distance migrated. The sample spot was scraped for
measurement of radioactivity. In all instances, less than 2%
glutamate was found.
Animals
Male sprague-Dawley rats (Charles River, Montreal)
weighing 200-300g were used for all studies. Rats were
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allowed water and Purina rat chow ~ libitum.
Male Sprague-Dawley rats were made diabetic by a single
injection of streptozotocin into the tail vein under light
ether anaesthesia. The dose given was 100 mg/kg body wt as
previously reported (Brosnan §..t. ill....., 1983). The
streptozotocin ....as made up at a concentration of 60 mg/tnl of
sodium citrate buffer, pH 4.5 and injected immediately.
Insulin treatment started 24 hours after the
streptozotocin inj ection. Diabetic rats were maintained on
Protamine zinc insulin (PZI) for five days. Daily
subcutaneous insulin injections were given between 13:00-14:00
hours. A control group of insulin-maintained diabetic rats
were kept on insulin up to the day of experimentation. Blood
glucose levels were monitored by obtaining a drop of blood
from the tail vein and determining blood glucose by using an
Ames Glucometer GX (Miles Canada Inc., Etobicoke, ontario).
Insulin dosages were adjusted to maintain normal blood glucose
(4-6 tnM) levels and ....eight gain. A blood sample from the
portal vein ....as taken on the day of the experiment for later
determination of plasmtl glucose levels. Plasma insulin and
glucagon levels were not determined.
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METHODS
preparation of Hepatocytes
Hepatocytes were prepared essentially as described
previously (Krebs tl~, 1974) except t.hat hyaluronidase ....as
omitted from the perfusate. Rats uere anaesthetized with
pentabarbitol. The femoral vein was exposed and 0.1 m1 of
:heparin was injected. The isolation of hepatocytes involved
perfusing rat liver first with 500 rol of calcium-free Krebs-
Henseleit bicarbonate medium containing 2 mM EG'l';., 20 roM
glucose, 2.1 roM lactate, and 0.3 mM pyruvate. The flow rate
in all cases was approximately 40 rol/minute, all media were
gassed with 95:5 02:C02 for 20 minutes prior to usage and
gassing continued throughout the isolation procedure. This was
followed by 500 m1 of Krebs-Henseleit medium which contained
2.5 rnM calcium, 20 lnM glucose, 2.1 mM lactate, and 0.3 mM
pyruvate. calcium-containing Krebs-Henseleit medium with
0.25% bovine serum albumin (fraction V essentially fatty acid
free) and 15 rng collagenase/100 ml was then recirculated for
15 to 20 minutes in a total volume of 200 ml. After this
recirculation of 15 to 20 minutes, the liver began to leak
medium and was observed to break apart, and at this point the
liver was removed and minced in a petri dish. This suspension
was then shaken in a Dubnoff metabolic shaker at 37°C under
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0l/COl (95:5) for ten minutes. The cells were then spun down
at 600 rpm and washed two more tilles in Krebs-Henseleit
medium. The final wash was in Krebs-Henseleit mediull containg
2.5' BSA and the final suspension of cells was also in this
medium. cell viability ,",;as determined by 0.2' trypan blue
exclusion and wa!1 greater than 95' in all instances. Cells
were quantified by determining their dry weight. A 3 ml
aliquot of cell suspension was placed in a metal weighing pan
and a 3 ml aliquot of the 2.5\ BSA resuspension medium was
placed in a separate weighing pan. Both were dried in an oven
at 50Ge for 24 hours. The difference in weight of the cell
suspension and the medium was used to determine the dry weight
of the cells present.
For the studies on streptozotocin-diabetic rats, a
calcium concentration of 1.25 IlM was used in the perfusions
but the cells were still resuspended in 2.5 mM calcium Krebs-
Henseleit medium with 2.5\ 55.... This stelllnled from initial
studies where the calcium concentration was found to affect
the overall success of the perfusion. When the perfusion
medium was switched from calcium-free to 2.5 mM calcium-
containing medium, the flow was observed to immediately slow
down and eventually stop completely. Using 1.25 11IM calcium
prevented this and allowed for the isolation of viable cells.
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preparati.on or Mitochondria
Mitochondria were isolated from livers of male Sprague-
Dawley rats as described previously (.lois gt i!.L., 1989). Rats
were killed by cervical dislocation and the liver was quickly
removed. The liver was homogenized, using a Potter-Elvejhem
hand-held homogenizer, in an iC2-cold medium containing 0.225
M mannitol, 0.075 M sucrose, 5 mM HEPES, and 1 mM EGTA. The
homogenate was centrifuged for 10 minutes at 600 x 9 and the
supernatant was then centrifuged at 8200 x g for 10 minutes.
The resulting pellet was resuspended in the above medium and
centrifuged at B200 x 9 for 10 minutes. The resuspension and
centrifugation steps were repeated two times and the final
pellet was resuspended in a small volume of the above medium.
The respiratory control ratio was determined polarographically
at 30°C with 10 mM (I-ketoglutarate as substrate and was
greater than 4 in all cases. The incubation medium contained
140 roM Kel, 5 mM Tris, 4 mM KHzP04, 2.5 mM MgClz1 and 1.5 mM
EDTA and was adjusted to pH 7.4. A standard biuret procedure
was used for determining the protein concentration of the
mitochondrial suspension (Gornall ~~, 1949). Bovine serum
albumin was used as standard.
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Preparation of Liver Hit.ochondria froll Diabetic Rats
Liver mitochondria isolated fro. diabetic rats using
standard procedures were found to have poor respiratory
control ratios. This has been reported by other investigators
for both alloxan-induced diabetes CHarano .I..t.~. 1972; Lerner
ll.Al....... 1972) and streptozotocin-induced diabetes (Brignane~
A.L., 1982; Grinble.t g,t~. 1968). This he.s been attributed
to decreased state 3 respiration due to an inhibition of
adenine nucleotide penetration (Harano I.t.ll....., 1972; Lerner ~
lli. 1972). This may be a consequence of increased hepatic
lipid content., pe.rticularly long chain acyl-CoA esters, which
occurs in diabetes and is known to inhibit the adenine
nucleotide translocase (Lerner!l.t. lli, 1972). Similar
resul ts have been found during hibernation and exhaustive
exercise (Lerner n Alt., 1972; Klug n Al...., 1984; Soball &
ilL.., 1985; Bode II Al....... 1990).
The sluggish response to AOP in liver mitochondria lDay be
partially reversed by addition of high concentrations of
bovine serum albumin to the isolation medium (Lerner itt. lli.
1972). Simile" procedures have been used to reverse the poor
response in liver mitochondria isolated from rats previously
exposed to exhaustive exercise (Klug i.t AL.., 1984; Bode i.t
lli. 1990).
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We devised a procedure which permitted us to isolate
well-coupled mitochondria from streptozotocin-diabetic rats.
The key point was to flush the liver with a mitochondrial
homogenization medium that contained a high concentration of
serum albumin. Thus the extracellular space was replaced with
this medium so that, upon homogenization, lipids were
efficently complexed. To isolate liver mitochondria from
streptozotocin diabetic rats, the rats were anaesthetized with
pentabarbitol. The femoral vein was exposed and 0.1 ml (100
units) of heparin injected. The body cavity was opened to
expose the liver. Ties were placed around the hepatic artery
and the portal vein. In order to reduce the fatty acid
content of the liver, it was first washed wj ~.h 50 ml of
mitochondrial isolation medium containing 50 mg bovine serum
albumin (fraction V, essentially fatty acid free BSAI/ml
through a portal vein cannula. The medium was equilibrated at
37°C before use. A 50 ml syringe containing the medium was
attached to the cannula, the hepatic artery was tied off and
the vena cava cut. The liver was then slowly flushed with the
eSA-containing isolation medium. Immediately the liver was
removed and placed in ice-cold isolation medium containing 5
mg BSA/ml. The liver was homogenized in this medium. The
centrifugation and resuspension steps were the same as the
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standard mitochondrial isolation procedure except that all
media contained 5 mg eSA/ml. The respiratory control ratio
was determined u!:lng the previously stated procedure. Livers
from control, insulin-maintained diabetic, and diabetic rats
were subjected to this procedure.
Preparation ot: Mitochondrial Meml:lranl!lS
Glutaminase assays were carried out on mitochondrial
membranes prepared as described by Szweda and Atkinson
(1990a). This involved preparing mitochondria using the
standard isolation procedure. The mitochondrial pellet was
resuspended in isolation medium (0.225 M mannitol, 0.075 M
sucrose, 5 mM Hepes, and 1 roM EGTA), and then diluted 1:1 with
distilled water. The mitochondria were disrupted by freezing
in liquid nitrogen and were then thawed in water at )7°C.
This freezing and thawing was repeated three times (Szweda and
Atkinson, 1990a). The suspension was diluted 1:4 with
mitochondrial isolation medium and this was followed by
centrifugation at 40,000 x 9 for 20 minutes to isolate the
membrane fra-::tion. The pellet resuspended in
mitochondri<.l isolation medium and adjusted to a final protein
concentration of 20 mg/ml.
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Isolation of Mitochondria from Hepatocytes
Hepatocytes were isclated from the livers of fed rats as
previously indicated. These hepatocytes were incubated at
37°C under 0z/COz (95:5) in a shaking water bath with 10-7M
glucagon (dissolved in 10 roM Hel) or 1 /lM okadaic acid
(dissolved in DMSO). control incubations contained an
equivalent amount of 10 mM HCl or DMSO, respectively. All
incubations were at a final volume of 20 ml in so ml
Erlenmeyer flasks and were gassed with 95:5 02:COZ' The
incubation was terminated by spinning the hepatocytes at 600
rpm for 2 minutes to remove the Krebs-Henseleit medium. A
modification of a procedure used by Covera and Garcia-Sainz
(1983) was used to obtain the mitochondria. In this method
digitonin is used to disrupt the plasma membranes and per-.::it
the release of mitochondria. The cells were resuspended in
isolation medium containing 0.225 Mmannitol, 0.075 M sucrose,
5 rnM HEPES, 1 rnM EGTA and 0.4 mg digitonin/ml. 'l'he cells were
sUbjected to a high speed spin (8200 x g) for two minutes.
The cell pellet was homogenized in digitonin-free isolation
medium using ten strokes of a Potter-Elvejhem hand-held
homogenizer. The suspension was then sUbjected to the same
procedure as used for the isolation of mitochondria from
intact liver. Again, the respiratory control ratio was
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checked using a Clark oxygen electrode ....ith 10 mM a-
ketoglutarate substrate and was greater than 3 in all
M••sur_ent of flux throuqb qlutaainase in isolated
h.p.tocytes
The procedure for determining flux through glutaminase
involves the trapping and counting of "C02 after incubation of
cells with (1-'4cJgl lltamine (1 mM) (Vincent g,t .5lL... 1989).
Incubations were in triplicate in 25 ml Erlenmeyer flasks
containing between 4-6 mq dry weight ot hepatocytes in a final
volume of 1 1Ill. Cells were preincubated in Krebs-Henseleit
medium for 20 minutes at 37°C before the addition of (1-
14C)glutalD.ine to give a final concentration of 1 mH. Where
indicated, afQllloniulll chloride was added at the same time as the
[1-'4C)qlutamine. !:ach flask was gassed with 95:5 02:C02 tor
20 seconds aftar the addition of the cells and also after
addition of [1-"C]glutamine. The incubation flasks were
equipped with rubber septa in which plastic centre wells were
suspended. NCS tissue solubilizer was introduced into centre
wells through the septa just before termination of incubation
with 0.15 ml of 30t (W/v) .lerchlorlc acid. "C02 was collected
for one hour and the centre wells were then transferred to
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scintillation vials containing 15 ml ot scint1l13.tion nuid
(Omnifluor) and radioactivity was determined.
There are two potential problems with using CO2 release
to measure nux through glutaminase. The first stems from the
fact that there are two steps between glutaminase and the
actual release of CO2 by a-ketoglutarate dehydrogenase. Thus
CO2 release is somewhat removed from the actual enzyme being
measured and there is opportunity for isotope dilution to
occur. The second complication arises because the isolated
hepatocyte suspension contains periportal cells with
glutaminase and perivenous cells with glutamine synthetase.
Thus glutamate. produced by glutaminase, could be
resynthesized. into glutamine by glutamine synthetase without
release of 14C02 (see Figure 2.1). This would underestimate
the extent of glutamine utilization by glutaminase.
Methionine sulfoximine (MSO) , hOlJever, can be used as an
inhibitor of glutamine synthetase (Meister, 1968).
To test tha validity of using "C02 release from {1-
14C)glutamine to determine glutaminase flux, glutamine
disappearance was determined chemically and 14C02 was
simUltaneously collected both in the presence and absence of
1 mM methionine sulfoximine (Vincent At. AL., 1989). This
procedure will detormine whether glutamine disappearance in
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Piqura 2.1. Illustration of Potential Problems of osing '4002
R.I•••• from [l-"C] Glutamine to Determine Flux Through
Glut..inas. in Isol.ted Hepatocytes
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the presence of methionine sulfoximine was equal to 14C02
release and also whether methionine sulfoximine was necessary
for the (1_ 14C] glutamine assay.
Each 25 tnl Erlenmeyer flask contained 3 ml of Krebs-
2Henseleit medium with approximately 45 mg dry weight
cells/flask. The flasks were gassed with 95:5 02: CO2 and the
hepatocytes were preincubated for 20 minutes at 37°C. The
reaction was started by adding 1 mM (1-'~CJglutamine, 2 mM
NH~cI. and, where indicated, 10.1 M glucagon to the flasks.
Immediately a 1 ml sample was taken and added to 0.2 ml of 30%
perchloric acid for glutamine and glutamate determinations in
these zero time or initial samples. After 30 minutes, 1 rol
samples were removed from the flasks and added to perchloric
acid for glutamine and glutamate measurements. The incubation
of the remaining 1 tnl was stopped by adding 0.2 tnl of 30\
perchloric acid to the flasks. '~C02 was trapped as
previously described. Glutamine was determined enzymatically
by employing glutaminase and glutamate dehydrogenase (Lund,
1974) . Glutamate was determined using the glutamate
dehydrogenase method (Bernt & Bergmeyer, 1974).
Table 2.1 gives glutamine disappearance, glutamate
formation and '~C02 production. In this study a concentrated
cell suspension was used since more cells were required in
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'l'aJ:)~. 2. ,1. G~utaJlline Disappearance and 14COZ Release in :Isolated Hepatocyt••-
Values are Mean :1: SEM tor the number ot experiments indicated in parentheses, and are
expressed as ruDol.51 mg dry wt./min. The concentrations used are 1 mM 1-14C-Glutamine,
2 mM ammonium chloride, 10·7M glucagon, and 1 IIlM methionine su1~oxillline. Normal, non-
diabetic rats were used.
(* P<O.05 vs no adl1ed glucagon, • P<O.O!5 vs no al1ded MSO).
Additions Glutamine 14C O Z Glutamata Glutaminedisappearance reloase formation \l,isappearncft
~ COl release
-0.062 :!: 0.09 0.19 :t 0.01 0.11 ± 0.0l.
(5) (5) (5)
"SO 0.18 :!: 0.04' 0.20 :t 0.01 0.15 ± 0.02 0.89
(5) (5) (5)
Glucagon 0.1:0: ± 0.05 0.35 ± 0.02' 0.047 :!: 0.01· 0.34
(4) (4) (4)
Glucagon + 0.25 ± 0.03 0.32 ± 0.01" 0.068 ± 0.01" 0.79
"SO (J) (4) (4)
- Experiment cOlllplated with H. Stephen Ewart and is also contained in his Ph. D. Thesis.
order to accurately determine changes in glutamine and
glutamate. This cell concentration was also used by other
investigators (Vincent !rt. li......, 1989). The results of Table
2.1 indicate that in the absence of added MSO, glutamine
disappearance was not found but "COz release did occur. This
suggests that glutamine disappearance determined enzymatically
in the absence of MSO is underestimating glutaminase flux due
to the production of glutamine by glutamine synthetase in the
perivenous hepatocytes. In the presence of 1 mM MSO,
glutamine disappearance was the same as 14COz release (0.18 ±
0.04 vs 0.20 ± 0.01 nmoles/mg dry weight cells/min.). It
should also be noted that "COz release was unaffected by the
presence of MSO. Thus 14COZ release does represent a valid
method for determining flux through glutanlinase.
Glycogenolysis in isolated hepatocytes
Glycogenolysis was determined in hepatocytes isolated
from fed rats uoing the amount of glucose produced over a 30
minute time period. Incubations were in triplicate with a
final volume of 1 ml in 25 ml Erlenmeyer flasks. The
incubations were in 2.5 mM caz·-containing Krebs-Henseleit
medium, gassed with 95:5 0z:C02, and where indicated Rp-cAMPS
was added with the cells and sUbjected to a 20 minute
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preincubation at 37°C before the addition of Sp-cAMPS or
glucagon. The amount of glucose formed during this
preincubation was subtracted in the calculation of the glucose
formed during the 30 minute incubation. After 30 minutes at
37°C in a Oubnoff metabolic shaker, the reactions were stopped
by adding 0.15 ml of 30% peA (wjv). The contents of the flask
were poured into Eppendorf tubes and centrifuged at 12,000 g
for 2 minutes. The supernatant was neutralized with 3 M ~PO,
and glucose was assayed in the supernatant using a standard
method (Bergmeyer II ilL., 1974).
Glutaminase Flux in I~olated Mitochondria
Isolated mitochondria were incubated in 25 rnl Erlenmeyer
flasks for 10 minutes at JOoC. All incubations were in
triplicate and each flask contained 2-3 mg mitochondrial
protein. The incubation medium contained 0.1 M KCl, 10 mM
Tria, 10 rnM K2HPO" 4 mM succinate, 10 mM KHCO], 13 ~M
rotenone, 1 mM EGTA, and 20 mM glutamine (Lacey ll.a..L.., 1981).
After 10 minutes, the reaction was stopped with 0.3 ml of
perchloric acid (7% wjv). For zero time samples 0.3 ml of
perchloric acid was added before the mitochondria. The
protein was then removed by centrifugation in an Eppendorf
microcentrifuge for 2 minutes at 12,000 x g. The supernatant
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was taken and adjusted to pH 8.8 with 3 M K,:P04 and was then
used for the glutamate assay (Bernt and Bergmeyer, 1974).
Glutamate formation was calculated as the difference between
the total flask contents at zero time and aft.er the 10 minute
period of incubation. since rotenone was present to prevent
further glutamate oxidation, the amount of glutamate formed
was a measure of flux through glutaminase.
Measurement ot. Glutaminase Activity in Mitochondrial Membranes
The membranes isolated from freeze-thawed mitochondria
were incubated at 37°C in 300 trIM mannitol, 10 rnM Hepes, 20 mM
glutamine, 0.7 rnM NH4Cl and various concentrations of
phosphate at pH 7.4 (Szweda and Atkinson, 1990a). The
reaction was started by adding 50 ~l of 20 mg/ml of membranes
to give a fina'. protein concentration of 1 mglml. The
reaction was terminated after 10 minutes by adding 0.3 ml of
7% (w/v) perchloric acid. The supernatant was adjusted to pH
8.8 with K,P04 and glutamate was determined using a glutamate
dehydrogenase assay (Bernt and Bergmeyer, 1974).
Portal plasma glucose concentration
Rats were anaesthetized with pentabarbitol and a blood
sample was withdrawn fro:n the portal vein using a heparinized
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syringe. This blood sample .....as placed in an Eppendorf
centrifuge tube and centrifuged for 2 minutes, (12,000 g,
SeC), to separate the plasma. The plasma sample .....as stored at
-20°C for later determination of plasma glucose using a
standard method (Bergmeyer n i.l......, 1974).
Statistical Analysis
All values are expressed as Mean ± SO or Mean ± SEM as
indicated. statistical analysis was by student's t-test or
paired t-test as indicated. Multiple comparisons were tested
using ANOVA and the Tukey mUltiple comparison test.
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CHAPTER 3
RESULTS AND DISCUSSION
DIABETES MELLITUS AND GLUTAMINE CATABOLISM
INTRODUCTION
Diabetes mellitus represents a physiological disorder in
which hyperglucagonemia is a major characteristic. Glutamine
can serve as a precursor for glucose synthesis in the liver.
Hepatic glutaminase is known to be regulated by glucogenic
hormones such as glucagon. stemming from these facts, a
number of questions arise regarding hepatic glutamine
catabolism in diabetes mellitus. These questions will be
examined using streptozotocin-induced diabetes as a model.
RESULTS
Portal plasma glucose levels and body weights
Rats were made diabetic by a single injection of
streptozotocin into the tail vein. The dose given was 100 rng
streptozotocinjkg body weight. Blood glucose levels were
determined by obtaining a drop of blood from the tail vein and
using an Ames Glucometer GX. Twenty-four hours after the
streptozotocin injection, blood glucose levels were greater
than 12 mM thus confirming the induction of diabetes.
Diabetic rats were maintained on daily subcutaneous insulin
injections for five days and then insulin was withheld for
five days preceeding the day of the experiment. A control
group received daily insulin injections until the day of the
S6
experiment. A third, non-diabetic control, group was also
used. On the day of the experiment, the rats were weighed and
a blood sample was taken from the portal vein. The portal
plasma glucose levels and body weights are given in Table 3.1-
These values are t ......: the actual day of the experiment. The
hepatic portal vein was chosen since it is the major blood
supply to the liver. These results show that insulin
treatment of diabetic rats for appreximately ten days brings
the portal plasma glucose levels back to normal, non-diabetic
levels. The portal plasma glucose in the diabetic rats was
significantly higher than in the normal and the insulin-
maintained diabetic animals. The body weight was also
significantly lower in this group.
Flux through glutaminase in isolated hepatocytes
The first question to be answered is whether
streptozotocin-induced diabetes results in increased flux
through glutaminase in isolated hepatocytes. Connected to
this question is whether daily insulin treatment of diabetic
rats could prevent any increase observed. Therefore, flux
through glutaminase in hepatocytes isolated from the three
different groups of animals was examined. Since ammonia is an
activator of glutaminase, three different ammonia
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Table 3.1 Portal Plasma Glucose Levels and Body Weights
Values given are mean ± SEM for the number of animals
indicated. Glucose was enzymatically determined using the
glucose-6-phosphatase dehydrogenase/hexokinase method.
* P<O.05 vs. normal and insulin-maintained.
Rat Type Portal Plasma Body wt.
Glucose (g)
(mM)
Control, non-diabetic 9.1 ± 0.6 340 ± 13
(12)
Insulin-Maintained Diabetic 8.0 ± 1.5 330 ± 6
(11)
Diabetic 29.2 ± 1.7* 298 ± 9*
(12)
5.
concentrations ....ere used in these studies. Glutaminase flux
in isolated hepatocytes was determined by measuring 1'C02
produced from [1_1'clglutamine in the absence of MSO. This
method ....as validated in Chapter 2 as an accurate method of
meas'..lring glutaminase flux.
Table 3.2 gives data on the flux through glutaminase in
isolated hepatocytes from control, insulin-maintained
diabetic, and diabetic rats. with no added ammonium chloride,
flux through glutaminase is low for the three groups although
the flux is higher in the diabetic group compared to the
insulin-maintained group. At a near-physiological portal vein
concentration of 0.5 mM ammonium chloride, flux through
glutaminase in the hepatocytes isolated from the diabetic rats
is significantly higher than in hepatocytes from the non-
diabetic controls or insulin-maintained diabetic. Thus
diabetes stimulated flux through glutalninase and daily insulin
treatment prevented the increase in flux in these isolatd
hepatocytes. At 2 roM added ammonium chloride, glutaminase
flux is increased in the three groups and there is no
significant difference among the three although the
significant trend seen at 0.5 roM NH,Cl is still evident.
The glucogenic hormone glucagon has been shown to
stimulate flux through glutaminase in perfused rat liver
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Table 3.2 Flux Through Glutaminase in Isolatel! Hepatoyte. tro.
control, Insulin-maintained Diabetic, anI! Diebetic Rats
Glutaminase flux in isolated hepatocyte,: as detenained by "CO2
release. Values are mean t SEM: n-4 for control and diabetic,
n-3 for insulin-maintained diabetic. Final concentrations:
glucagon 0.1 ~M, epinephrine 1.0 ~M, [l-UC1Glutamine 1 mH.
Each flask contained bet",een 4-6 IIIg dry weight of hepatocytea.
Rats ",ere made diabetic with an injection (If 10..' mg
streptozotocin/kg body ",eight. (a,b represent p<c.OS ve.
control and insulin-maintained, rel:>pectively, using the Tukey
mUltiple comparison test. * P<O.05 vS no added hormone at
NH,Cl concentration indicated; paired t-test)
Control Insulin- Diabetic
maintained
No Addition 5.55 ± 0.64 '\.56 ± 0.34 7.10 t 0.6Sb
+ Glucagon !i.62 ± 0.64 5.19 ± 0.33 8.03 ± 0.72·,b
+ Epinephrine 8.10 ± 0.69 6.57 ± 0.94 11.58 ± 1.64b
+ 0.5 :mM NH,CI 6.98 ± 1.28 5.43 ± 1.58 13.74 ± 2.0g·,b
+ Glucagon 9.58 ± 0.60 12.63 ± 0.60"" 19.85 ± 3.41""
+ Epinephrine 13.73 ± 0.95" 19.02 ± 1.10"" 30.67 ± 4.70""
+ 2 mM NH,CI 19.67 ± 3.11 21.70 ± 2.69 33.20 ± 5.87
+ Glucagon 39.57 ± 4.20· 40.00 ± 4.52" 45.73 ± 4.74"
+ Epinephrine 45.93 ± 3.66· 37.27 ± 3.71" 61.02 ± 9.37"
..
(HaUssinger ~ lli, 1983) and in isolated hepatocytes (Covera
and Garcia-sainz, 1983). Glucose production in isolated
hepatocytes wi th glutamine as the substrate is also increased
with glucagon (Joseph n.s.l...., 1978). It has been previously
shown that glucagon, and the catecholamine epinephrine,
increase flux through the glycine cleavage enzyme system in
isolated hepatocytes (Jois ll.itl......, 1989). This enzyme system,
like glutaminase, is located within the mitochondria. Thus
the third question examined is whether glucagon and
epinephrine stimulate glutaminase flux in isolated hepatocytes
and, if so, are there any differences among the three groups.
Therefore, as indicated in Table 3.2, the €!ffects of glucagon
and epinephrine on glutaminase flux in isolated hepatocytes
was examined. In the absence of added ammonium chloride there
was no stimulation by either glucagon or epinephrine. In the
presence of 0.5 mM added ammonium chloride, epinephrine
stimulated flux in the isolated hepatocytes from the three
groups. Significant glucagon stimulation of glutaminase flux
occurred in hepatocytes isolated from the insulin-maintained
diabetic and the diabetic rats. The pattern of stimulation is
similar in hepatocytes from control and diabetic rats. Both
glucagon and epinephrine stimulated glutaminase flux to a
greater extent in hepatocytes isolated from insulin-maintained
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diabetic rats than in those from control and diabetic rats.
The reason for this is unclear but it may be related to
possible alterations in the insulin:qlll ~aqon ratio caused by
the subcutaneous injections of insulin. This would also
account for the lower basal rates observed with the
hepatocytes from the insulin-maintained diabetics. Both
glucagon and epinephrine stimulated glutamina:.>e flux at 2: mM
added ammonium chloride.
Glutaminase Flux in Isolated Mitochondria
A fourth question examined is whether glutaminase flux is
stimulated in mitochondria isolated from livers of diabetic
rats. There was, initially, a problem in addressing this
question. Using standard differential centrifugation
procedures, liver mitochondria isolated from diabetic rata
have been found to have poor respiratory control ratios
(Lerner g.t i!.!......., 1972; Grinblat g.t i!.L.., 1988). This has been
attributed \:? decreased state 3 respiration due to an
inhibition of adenine nucleotide penetration possibly caused
by an increased hepatic lipid content. It was therefore
decided to flush the liver with a mitochondrial homogenization
medium that contained a high concentration of serum albumin in
an attempt to complex any lipids present. using this BSA
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perfusion technique, liver mitochondria were isolated .:rom
control, insulin-maintained diabetic, and diabetic rats. The
respiratory control ratios were not different among the three
groups and indicate that the mitochondria are well coupled.
It was established by Lacey II AL. (1981) that
glutaminase flux in intact mitochondria from glucagon-injected
rats was more sensitive to activation by inorganic phosphate
(Le. the phosphate aci:ivation curve is left-shifted). This
was not evident, however, when glutaminase was assayed in
broken mitochondria. A similar phenomenon has been reported
by Ewart and Brosnan (1993) for glutamir...3e activated after
protein feeding. Therefore to determine whether diabetes
stimulates flux through glutaminase, three different added
phosphate concentrations were used in the incubations (Figure
3.1). At all phosphate concentrations used, glutaminase flux
in the mitochondria from the diabetic rats was signifi.::::antly
higher than in mitochondria from control, non-diabetic rats.
Flux through glutaminase in the mitochondria isolated from the
insulin-maintained diabetic rats was not as high as that from
the diabetics and was not significantly higher than in
the control, non-diat-etics as is indicated in Figure 3.1.
Although no significant differences were found, the flux in
the mitochondria from the insulin-maintained rats does seem to
OJ
be higher than that obtained in the non-diabetic controls.
Insulin treatment of strept02otr.Jcin diabetic rats may not
return the plasma glucagon levels to normal, non-diabetic
values (Patel, 1983; Brubaker tl Al...., 1991). Such an increase
in circulating glucagon levels may account for the higher
glutaminase flux. The insert to Figure J.l gives the ratio of
glutaminase flux determined at 20 rnM phosphate compared to
that at'. 2.5 mM phosphate. This ratio is significantly higher
for the control, non-diabetics compared to the diabetics.
This indicates that, similar to the results with the glucagon-
injected rats, there is some left-shifting of the phosphate
curve for glutaminase. The hyperglucagonemic situation found
in diabetes mellitus could, possibly, also be increasing the
sensitivity of glutaminase for inorganic phosphate.
There "'"Ce, however, other possible reasons for this
increased glutaminase flux. One such possibility is that
there is more ammonia present in the mitochondrial preparation
prepared from the diabetic rats. Glutaminase is clearly
stimulated by its product, ammonia, and if there were more
ammonia associated with the diabetic mitochondria then this
could account for the increase in glutaminase flux observed.
To test this, glutaminase flux was determined in the presence
of 10 roM phosphate and a maximal stimulatory NH,Cl
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concentration of 1 mH. Under these conditions, glutaminase
flux was still observed to be higher in the mitochondria
isolated from the diabetic rats (16.5 nmo1es/min per mg
protein for control vs. 44.6 nmoles/min per mg protein for
diabetic; average of two experiments). This indicates that
the increase in flux observed in the diabetics can not be due
to more ammonia being present in the diabetic mitochondrial
preparation since even in the presence of a maximal
stimulatory added ammonia concentration the increase
associated with diabetes is still observed.
Glutaminase activity determined u9ing mitochondrial membranes
Lacey g,t u.... (1981) found that the left-shift of the
phosphate curve seen in intact mitochondria from 9luca~·...,n­
injected rats was not seen when examined in broken
mitochondria. In fact, there was no difference in glutaminase
activity at any phosphate concentration tested. In this
particular situation involving glucagon-injected rats, the
mitochondria were iSGlated twenty minutes after the injection.
In this short amount of time it is unlikely that there is an
increase in the amount of glutaminase protein. With
streptozotocin-induced diabetes, however, there are ten days
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Pigure 3.1 GlutllJQinase Plux in Isolated HitochoniSr~a
LivQr mitochondria wore isolated using the BSA perfusion
method as indicated ..i.n Chapter 2. Glutaminase flux was
determined using 20 mM glutamine and the indicated phosphate
concentration. The insert shows the ratio of glutaminase flux
at 20 11IM phosphate compared to flux at 2.5 mM phosphate. The
respiratory control ratios were determined in the presence of
10 mM a-ketoglutarate and were 4.2 ± 0.3, 4.6 ± 0.3, and 4.2
± 0.2, for control, insulin-maintained, and diabetic,
respectively. Values are mean ± SEM; n=4. (* P<0.05 vs
control) .
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between the induction of diabetes and the actual determination
of glutaminase nux. Therefore with diabetes it is possible
that there is an increase in total glutaminase activity due to
more glutaminase protein being present. Thus gluta1Dinase
activity was determined using mitochondrial membranes prepared
from freeze-thawed mitochondria. Two ditfernt added phosphate
concentrations were used, 10 mM and 40 mM. As is indicated in
Table 3.3, glutaminase activity is increased in the diabetic
rats. Maintaining the diabetics on insulin prevented this
increase. Similar results have been reported for glutaminase
activity in liver homogenates from streptozotocin diabetic
rats (Watford ~ £L., 1984). This study also found that
insulin treatment of diabetic rats prevented the increase 1n
glutaminase activity.
An interesting result in Table 3.3 shoW's that when the
ratio of glutaminase activity at 40 11M phosphate is compared
to that at 10 mM phosphate, it is 2 for both the control and
the insulin-maintained diabetic. This ratio was, however,
approximately 1. 5 for the diabetics. Initially I thought that
this was an error of some sort. Therefore, the experiment was
repeated for the streptozotocL,-induced diabetic group. The
results were essentially the same. The ratio of glutaminase
activity at 40 mM phosphate compared to 10 mM phosphate was
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found to be 1.6 (97.9 ± 10.3 VS. 59.6 ± 5.S nmoles/min per mg
protein 1 n=3). Thus it app~ars that there is a slight change
in the sensitivIty of glutaminase for phosphate even when
assayed in broken mitochondria from diabetic rats. This
requires more investigation but it is conceivable that a
stable change in glutaminase properties in diabetes may have
been uncovered.
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Table 3.3 Gllltalllinase Activity in Mitochondrial MelDbranea
Glutaminase activity was detelllined, using mitochondrial
melDbranes prepaled trom freeze-thawed mitochondria, in the
presence of 20 111M glutamine, 0.5 IllM NH4Cl. and the phosphate
concentrations indicated. Values given are n.o~es glutamate
formed/mg protein per minute and are mean ± SEM for the
indicated number ot. preparations. * P<O. 05 vs. control and
insulin-maintained.
Added Control, non- rnsulin- Diabetic (4)
Phosphate diabetic (4) maintained
diabetic (4)
'0 mM 28.7 ± 3.7 32.6 ± 4.S 80.6 t 5.8'
40 mM 56.0 ± 4.3 64.3 ± 4.S 123.4 ± 8.6"
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DISCUSSION
Diabetes mellitus is characterized by a decrease in or
total lack of insulin action and a relative increase in
counter regUlatory hormones such as glucagon. A major problem
associated \lith diabetes is continued production of glucose by
gluconeogenesis even in the presence of hyperglycemia.
Glutamine, being a glucogenic amino acid, can be converted to
glucose in the liver. The first step in this conversion
involves the formation of glutamate from glutamine,
conversion catalysed by the mitochondrial enzyme glutaminase.
Hepatic glutaminase is regulated by hormones (Joseph and
McGivan, 1978a; Haussinger g ~, 1983; Table 3.2).
Associated with diabetes mellitus is an increase in
glutamina"'e activity due to more glutaminase protein (Watford
II Ah, 1984; Smith and Watford, 1988). Previo'ls1y, however,
little attention has been given to the involvement of hormonal
changes in the regUlation of glutaminase in diabetes mellitus.
This was examined in more detail using both isolated
hepatocytes and isolated mitochondria from streptozotocin-
induced diabetic rats. The first question e~amined dealt with
glutaminase flu~ in isolated hepatocytes. The results of
Table 3.2 indicate that glutaminase flu~ was increased in the
hepatocytes from the diabetic group compared to the non-
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diabetic control group. Maintaining the diabetic rats on
daily insulin injections prevented the increase in glutaminase
flux in isolated hepatocytes.
Liver mitochondria isolated from diabetic rats using
conventional differential centrifugation techniques have
traditionally had poor respiratory control ratios. This was
solved in this study by flushing the liver with an
homogenization medium containing a high concentration of BSA
(50 mg/ml) and then isolating the mitochondria using a medium
containing Q. lower concentration of BSA (5 mg/ml). It was
believed that the poor respiratory ratios were due to high
hepatic lipid content which inhibited adenine nucleotide
penetration. BSA binds these lipids, enabling state J
respiration to be increased.
Glutaminase flux was examined in these "well-coupled"
mitochondria and it was found that the flux was significantly
increased in mitochondria from diabetic rats (Figure 3.1). A
major characteristic of glutaminase flux in mitochondria from
glucc"'!on-injected rats (Lacey tl ll..:.., 1981) and from high-
protein fed rats (Ewart and Brosnan, 1993) is an increased
sensitivity of glutaminase to phosphate. As shown in Figure
3.1, the ratio of glutaminase flux determined at 20 mM
phosphate compared to flux at 2.5 roM phosphate is much lower
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for the diabetics compared to the control and the insulin-
maintained groups. This clearly indicates an increased
sensitivity of glutaminase for phosphate in the mitochondria
from the diabetic rats and provides additional support for the
involvement of glucagon in the observed increase in
glutaminase flux.
The above results do not rule out the involvement of
increased glutaminase activity in contributing to the
increased glutaminase flux observed. Therefore, glutaminase
activity was determined using mitochondrial membranes prepared
from freeze-thawed mitochondria. The results of Table 3.3
indicate that, in agreement with previous published findings
(Watford tl sL.., 1984), glutaminase activity is increased with
diabetes and insulin treatment of the diabetic rat::; prevents
this increase. At 10 mM phosphate the glutaminase activity
increased by approximately 2.8 fold whereas the glutaminase
flux increased by 3.8 fold. Tnerefore the increased
glutaminase flux in isolated mitochondria cannot be accounted
for by only an increased glutaminase activity. Figure 3.1
also shows an increased sensitivity of glutaminase for
phosphate in the mitochondria from the diabetic rats. These
results indicate that glucagon is playing a significant role
in increasing glutaminase flux in the isolated mitochondria.
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The results obtained using the isolated hepatocytes can be
accounted for by the increase in glutaminase activity.
Previous studies with isolated hepatocytes and perfused rat
liver have shown decreased glucagon sensitivities in these
systems (Ewart, 1993). Therefore the hepatocyte results do
not rule out the involvement of glucagon in controlling
glutal1linase in diabetes.
Maintaining the streptozotocin diabetic rats on daily
insulin injections prevents or reverses the increase in
glutaminase flux in isolated hepatoc:ytes and isolated intact
liver mitochondria. Insulin treatment also prevents the
increase in glutaminase activity observed in mitochondrial
membranes from freeze-thawed mitochondria. This lends support
for the involvement of hormones in regUlating hepatic
glutaminase and strengthens the importance of the
insulin/glucagon ratio in the regulation of gluconeogenesis.
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Chapter 4
Results and Discussion
Honnonal Regulation of Glutaminase
INTRODUCTION
In the preceding section it was shown that the
mitochondrial enzyme glutaminase is subject to hormonal
control, being stimulated by glucagon and epinephrine. There
is still the question, however, of exactly how the hormonal
signal gets transmitted from the receptors on the plasma
membrane through the cytosol to the mitochondria. This aspect
of hormc,nal regulation will be examined in more detail in this
chapter.
RESULTS
Glucagon and Epinephrine Stimulation of Glutaminase
Liver glutaminase has been shown to be under hOrJ"r</'I. \1
regulation. In Figure 4.1 glutaminase flux was determined in
isolated hepatacytes in the presence of either epinephrine or
glucagon as a function of <Immonium concentration. These
results again demonstrate that glutaminase is stimulated by
ammonium chloride and also by the catecholamine epinephrine,
and the gluo0genio hormone glucagon. with no added ammonium
chloride, there was no stimulation of glutaminase by either
glucagon or epinephrine. In the presl::nce of ammonium
chloride, both hormones caused an increase in 14COZ release and
thus in flux through glutaminase. In the presence of 1 roM
NH4Cl, IO·7M vasopressin also stimulated glutaminase flux in
7.
Figure 4.1. Effects of Epinephrine and Glucagon on Flux
Through Glutaminase in :Isolated Hepatocytes
Flux through glutaminase in isolated hepatocytes determined
using I mM [l-'~c]glutamine and collecting 1~C02' In A.,
epinephrine ('). 10'6r1, was added to the incubations while (0)
represents the contrcl incubations. In B.• glucagon ("), 10·
7M, was added to the incubations while ('\7) represents control
incubations. since both hormones were dissolved in 10 ,.1M Hel,
the control incubations contained an equivalent amount of 10
toM HCl (0.1 mM final concentration). uepatocytes were
preincubated at 37°C in Krebs-Henseleit bic:'l.rbonate medium for
20 minutes before the addition of [1_1~C] glutamine, hormones,
and the indicated concentration of NH,CI. Values are nmoles
CO2 produced/mg dry wt. cells/30 min. and are mean ± SEM; n=4.
*P<O.05 va. no added hormone, paired t-test.
A.
60
50 ·.-l
40
.1/ 0...-6
30
.1/6/0 20
" 10/~ 10
~ ../
>- 0
"
0.0 0.5 1.0 1.5 2.0 25
'"E B.
16050
ON • T
u 40 T/T--":'~
.
. IT 1-~] 30
20 T J/
10 j~/
0
0.0 0.5 1.0 1.5 2.0 2.5
Added NH4Cl (mM)
78
isolated hepatocytes (16.8 ± 4.2 vs 31.4 6.1 nmoles CO2
produced/mg dry wt cells/30 min.).
Protein Phosphorylation and Glutil1llinase flux
A major unanswered question is exactly how and in what
form the hormonal signal is transmitted to the mitochondria to
affect enzymes such as glutaminase. The stimulation of
glutaminase by hormones such as glucagon is quite stable,
persisting in liver mitochondria isolated from rats previously
injected with glucagon (Lacey §.t. SlL.., 1981). This differs
from the effect of glucagon on the phosphol:ylation of key
cytoplasmic enzymes wherf! the phosphorylation is
metabolically labile and can be reversed by phosphatases. The
possibility does exist, however, that a phosphorylation step
may be involved in the overall signalling process. To examine
this further, the cytosolic protein phosphatase inhibitors
okadalc acid and calyculin A were used. As is indicated in
Figure 4.2 both of these phosphatase inhibitors caused a
significant increase in glutaminase flux in isolated
hepatocytes. The maximal effect was observed at 1 .uM added
okadaic acid or calyculin A. In SUbsequent experiments only
okadaic acid was used since there was no significant
difference between the two phosphatase inhibitors tested.
Figure 4.3 indicates that okadaic acid causes a slight
stimUlation in the absence of added NH4CI but this stimUlation
"
Figure 4.2. Effects of Protein Phosphatase Inhibitors on flux
through Glutaminase in Isolated Hepatocytes
Glutaminase flux in isolated heptocytes was determined in the
presence of 1 mM [1-1'Cjglutam1ne and 1 mM added NH,Cl.
Hepatocytes were pre incubated for 20 minutes at 37°C with
Okadaic acid (0) or calyculin A (I) before the reaction was
initiated by the addition of {1-1'C]glutamine (1 mM final
concentration) and NH,C1 (1 mM final concentration). Values
are nmoles cal produced/mg dry wt cel19/30 min and are mean ±
SEM; n=3 except at 10·5M (n=2). Control value in the absence
of Okadaic acid calyculin A was 16.5 ± 1.9 nmoles cal
produced/mg dry wt cells/30 mi..,. *P<O.OS vs. no added
inhibitor.
c
E 40
g
35
'c?e 30, ;,____1-
~ 25
'/'If 20 ~'l 15 pi. 0 Q1,adaic Acid1 • Calyculin A
o~ 10
u
.
.
l
10-9 10-8 10-7 10-6 10-5
Concenlralion (M)
.,
Fiqure f. 3. Ammonium Cbloride Curve for Flux Througb
Glut81llinase in Isolated Hepatocytes - Effects of 1 J.lM okadaio
),cid
Okadaic acid (') was added to the hepatocytes at the start of
a 20 minute preinCUbation at 37°C. The reaction was iniated by
the addition of (l-"C]glutamine, 1 mM final concentration,
and NH,Cl. (0) represents control incubations not containing
okadaic acid. Values are nmoles CO2 produced/rag dry wt.
cells/30 lIlin. and are lIlean ± SEM; n=3 ... P<O.OS V5. control;
paired t-test.
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was more evident in the p:.:'esence of added NH,Cl. A necessary
control experiment was to determine if okadaic acid has a
direct effect on glutaminase in isolated mitochondria. The
results given in Table 4.1 indicate that it does not. Thus it
appears that okadaic acid activates glutaminase through its
well defined effects on cytosolic protein phosphatases.
Does glucagon activate the mitochondrial enzyme
glutaminase in the same manner as does okadaic acid? To
examine this question furtt:er, a glucagon dose-response curve
was determined in the presence of a submaximal okadaic acid
concentration. This concentration, O. 01 ~M, produces a slight
sti.mu1ation of glutaminase flux in isolated hepatocytes. It
was thought that this low concentration of okadaic acid might
produce a left shift in the glucagon curve. Figure 4.4 shows
that this was not the case. This may indicate that glucagon
is operating through a separate signalling system from that
stimulated by okadaic acid or that there is more than one
signalling "system" operating simultaneously. For example,
glucagon may act either through increasing the levels of
phosphorylated proteins through cAMP-dependent
phosphorylation and/or by increasing the intracellular
concentrations of divalent catj~lns such as calcium (Wakelam n
ilL., 1986). It is possible that something in addition to the
activity of phosphorylated protein(s) exercises a high degree
of control in the signalling cascade .
..
Table 4.1. Glutaminase Flux in Isolated Mitochondria - Effects
of Oka"'-aic Acid
Values are mean ± SEM for four separate experiments.
Glutaminase flux was determined in the presence of 20 mM
glutamine and 10 JnM added phosphate. Mitochondria were
pre incubated at 30°C in the presence of okadaic acid bBfore
the addition of glutamine. The amount of glutamate formed was
used to determine flux through glutaminase. Glutamato
determined using the glutamate dehydrogenase assay.
nmoles glutamate formed/mg
mitOChondrial protein/min.
Control, H20
Control, DMSO
Okadaic Acid ,I IlM
.5
7.9 ± 1.9
7.9 ± 1.7
7.6 ± 1.5
Figure ...... Glueaqon curve for Glutaminase Flux in Isolated
Hepatocytes - Effects of submaximal okadaie acid
Glutaminase flux was determined in isolated hepatocytes using
"C02 release from 1 rnM (l_l'cJglutamine in the presence of 1 trIM
NH,Cl. 0.01 /.1M okadaic acid was added with the cells and
sUbjected to a 20 minute preincubation at 37°C. Glucagon was
added to the flasks, along with the [l-14C]glutamine, after the
20 minute preincubation period. Values are mean ± SEM, n-6.
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Protein kinase A, or cAMP-dependent protein kinase, is a
major kinase responsible for phosphorylating cytosolic
proteins. My results using the phosphatase inhibitors
indicate that phosphorylation of cytosolic protC?ln(s) may be
involved in the hormonal signalling process which causes
glutaminase flux to be increased. As indicated in Chapter 1,
Sp-cAMPS is an agonist for protein kinase A. It behaves in a
similar fashion to endogenous cAMP by binding to the
holoenzyme of protein kinase A allowing the active catalytic
subunit to be released. Rp-cAMPS is an antagonist for protein
kinase A since when it binds to the holoenzyme of protein
kinase A, the active catalytic subunit is not released and
thus the kinase is not activated. Both of these cAMP
analog'Ues have previously been used in isolated hepatocytes in
the examination of the regUlation of glycogenolysia and
gluconeogenesis (Rothermel n S!.L, 1983; Rothermel ~ .5l..L..,
1984). Therefore, I decided to use these compounds to further
examine the regulation of glutaminase in isolated hepatocytes.
Figure 4.5 shows that Sp-cAMPS stimulates flux through
glutaminase in isolated hepatocytes whereas Rp-cAMPS by itself
has no effect on glutaminase flux. Figure 4.6 indicates that,
like the hormones, Sp-cAMPS only stimulates glutaminase flux
in the presence of added ammonium chloride. Again, a
necessary control experiment is to examine whether Sp-cAMPS
ss
Figure 4.5. Effects of cAMP analogues, Sp-cAHPB and Rp-cAMPS,
on Flux Through Glutaminase in Isolated Hepatocytes
Sp-cAMPS (0) or Rp-cAMPS (t) was added with the hepatocytes
and sUbjected to a 20 minute preincubation at )7°C. After
this preincubation [1_14Cl glutamine and NH4Cl were added to
give final concentrations of I mM and 0.5 mM, respectively.
Values are nmoles CO2 produced/mg dry wt. cells/30 min. and
are mean ± SEM; n"'3. *P<0.05 vs Rp-cAMPS, paired t-test.
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Pig-ure 4.6. J.mmonium Chloride Curve wit.h 10-'M Sp-oAMPS for
Plux Through Glutaminaso in Isolated Hepatocytes
Sp-cAMPS (') was added to the hepatocytes at the start of a 20
minute preincubation at )7aC. Control incubations (0) were
also preincubated. After preincubation, (l_l')glutamine, 111M
final concentration, and NH,CI was added. Values are nmoles
CO2 produced/t1g dry wt. cells/3D min. and are mean ± SEM; n:..4.
* P<O.OS vs. control; paired t-test.
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Table 4.2 Glutaminase nux in isolated mitochondria - effects
of Bp-c1\MPS
Mitochondria were isolated from the livers of fed rats. The
glutaminase assay contained 10 mM pi and 20 roM glutamine.
Values are given as nmoles glutamate formed/mg mitochondrial
protein/min. and are mean ± SEM; n=3.
Glutaminase flux
(nmoles/mg protein/min)
control, H20
Sp-cAMPS, 10'5M
11.94 ± 3.56
10.98 ± 2.64
.3
has any effect on gluta,ninase in isolated intact mitochondria.
In this control experiment Sp-cAMPS was found to have no
direct effect on glutaminase flux in isolated mitochondria
(Table 4.2). These results indicate that Sp-cAMPS stlmulates
glutaminase by activating a cAMP-dependent protein kinase in
the cytosol.
Rp-cA:MPS is an antagonist for protein kinase A and has
been shown to inhibit the Sp-cAMPS stimulation of
glycogenolysis in isolated hepatocytes (Rothermel tl AL..,
1983). The question which arose is whether Rp-l":AMPS would
also be able to inhibit the Sp-cAMPS stimulated glutaminase
flux in isolated hepa+:.ocytes. If this were indeed true, it
would strengthen the view that. .sp-cAMPS, and also cAMP, causes
its stimulatory effects on glutaminase by activating a
cytosolic CAMP-dependent protein kinase. To determine this it
was first necessary to show that the antagonistic effect of
Rp-cAMPS was working in our isolated hepatocyte system. As a
control, the experiments of Rothermel II &..... (1983) were
repeated. As is indicated in Figure 4.7, Rp-cAMPS caused a
right-shift in the Sp-cAMPS curve for glycogenolysis in our
isolated hepatocyte system. Therefore, Rp-cAMPS did
antagonize Sp-cAMPS in our system, so we could p-xamine the
effect of Rp-cAM:PS on Sp-cAMPS stimu1ted glutaminase flux in
isolated hepatocytes. The results given in Figure 4.8
indicate that Rp-cAMPS also antagonizes the stimulation of
..
pigure ".7. Effects of Rp-cAMPS on Sp-cAMPS stimulated
glycogenolysis in isolated hepatocytes
Glycogenolysis was determined as glucose release from
hepatocytes isolated from fed rats. The perfusion m,,"(l.ia used
in the isolation procedure contained 20 mM glucose. 10·' Rp-
cAMPS was added with the cells at the start of a 20 minute
preincubation before the addition of Sp-cAMPS. After 30
minutes an aliquot was removed from each incubation flask and
added to a microcentrifuge tube containing 0.15 ml of 30\
perchloric acid (w/v). The supernatant was adjusted to pH 7.0
and this was used for the measurement of glucose by the
glucose-6-phosphate dehydrogenase / hexokinase method. Values
are mean ± SEM; n=4. *P<O.05 va control.
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Figure ... 8. Effects of Rp-cAMPB on Sp-cAHPS stimulated nux
through glutaminase in isolated hepatocytes
Glutaminase flux was determined by collecting '~C02 from 1 mM
[l_l~C]glutamine in the presence of 0.5 rnM added NH~Cl. In
(I), hepatocytes were preincubated for 20 minutes with lO'~M
Rp-cAMPS before the addition of Sp-cAMPS and [l_l~c]glutamille.
Control incubations (0) did not contain Rp-cAMPS. Values are
mean ± SEM; n-4. *P<O.05 VS. control, paired t-test.
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glutaminase by Sp~cAMPS. This indicates the involvemcnt ot
cAMP and protein kinase A in the activation of liver
glutaminase.
I then determined if Rp-cAHPS. the protein kinase A
antagonist, would inhibit the glucagon-induced increase in
glutall.inase flux: in isolated hepatocytes. Rp-cAMPS had been
used to inhibit the glucagon-induced increase in
glycogenolysis in isolated hepatocytes (Rothermel n AL..
1984). Repeating these experiments, I confirmed that Rp-cAMPS
caused a right-shift of the glucagon curve for glycogenolysis
(Figure 4.9) although the degree of right-shift was ll!.'>s than
that reported by Rothermel n ~ (1984). This confirms the
involvement of protein kinase A in the glucagon-induced
increase in glycogenolysis in isolated hepatocytes. No
inhibition of glucagon-stimulated glutaminase flux by Rp-cAHPS
was observed in isolated hepatocytes (Figure 4.10). This Ilay
indicate that glucagon is acting through more than one
signalling mechanism or the glucagon concentration required to
produce an effect on glutaminase causes such a large increase
in endogenous cAMP that Rp-cAMPS is unable to successfully
compete for binding to protein kinase A.
..
Figure of,. 9. Effect of Rp-cAMPS on glucagon stimulated
glycogenolysis in isolated hepatocytes
Glycogenolysis was determined as glucose production in
iaolated hepatocytes from fed rats. Rp~cAMPS (10-4 M) was
preincubated with the hepatocytes before the addition of
glucagon. This preincubation was in Krebs-Henseleit medium at
37°C for 20 minutes. Values given are nmoles glucose
producedjmg dry wt cells per 30 minutes and are mean ± SEM;
n-3. *P<O. 05 vs. control; paired t-test.
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figure ... 10. Effects of Rp-c1\MPS on glucagon stimulated flux
through glutaminase in isolated hepatocytes
Glutaminase flux was determined by collecting "C02 from 1 mM
[l_l~C] glutamine in the presence of 1 mM added NH~Cl. 10·4M
Rp-cAMPS was included in the 20 minute preincubation with the
hepatocytes before the reaction was initiated by the addition
of glucagon, NH4Cl and (l_14Clglutamine. Values given are
nmoles CO2 producod/mg dry wt. cells per 30 minutes and are
mean ± SEM; n"'3.
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Glut.aminase nux in mitochondria isolat.ed frolll hepatocyt.e.
The stimulation of glutaminase by hormones is
characterized by its stability once mitochondria have been
isolated. Lacey n li..... (1981) have shown that. liver
mitochondria isolated from glucagon-treated rats exhibit
increased flux compared to mitochondria from control rats.
This increase was observed in mitochondria isolated 25 minutes
after the glucagon injection even though no steps were taken
to preserve the phosphorylation state of the proteins. Also
in a previous study, Covera and Garcia-Sainz (19S3) isolated
mitochondria from hepatocytes previously incubated with
hormones and determined glutaminase flux in these
mitochondria. Th,.!ir results again indicate that a stable
hormonal signal in transmitted into the mitochondria within
the intact hepatocyte and this hormonal signal persists when
the mitochondria are isolated.
The experiments of Covera and Garcia-Sainz were repeated
using glucagon-treated hepatocytes and, as is indicated in
Figure 4.11, similar results were obtained. Mitochondria from
glucagon-treated hepatocytes have increased glutaminase flux
compared to those from control hepatocytes. The so-called O'
mitochondria were isolated from ttfresh" hepatocytes not
SUbjected to a 30 minute incubation at 37°C. Interestingly,
the glutaminase flux in the O' mitochondria was t i..gher than in
the control mitochondria isolated from hepatocytes which had
Figure 4.11. Glutamina'ile Flux in Mitochondria Isolated from
Hepatocytes - effects of 10-7M Glucagon
Isolated hepatocytes were incubated for JO minutes at 37°C in
the presence of 10·7M glucagon (in 10 ntH HC1) or an equivalent
amount of 10 ntH Hel, control. After 30 minutes, mitochondria
were isolated frCJm the hepatocytes using the digitonin method.
Mitochondria were also isolated from freshly isolated
hepatocytes not exposed to the 30 minute incubation at 37°C.
These are represented as 0' incubation. Glutaminase flux was
determined in the isolated mitochondria in the presence of 20
mM glutamine and 10 mM phosphate. Values are nmoles glutamate
formed/mg mitochondrial protein per minute and are mean ± SEM;
no4. '" P<0.05 vs. 30 minute control.
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been incubated at 37cC for 30 minutes. Covera and Garcia-
Sainz did not give the O'values. It appears that glucagon may
"prevent" the decrease in glutaminase flux observed after the
30 minute incubation of the hepatocytes. To examine this
further a time course was completed (Figure 4.12).
My previous results show that okadaic C'ocid increases
glutaminase flux in isolated hepatocytes. Therefore, the
question which arises is whether okadaic acid, like glucagon,
results in increased glutaminase flux in mitochondria isolated
from treated hepatocytes. The results given in Figure 4.13
indicate that mitochondria from okadaic acid-treated
hepatocytes exhibit higher glutaminase flux compared to
mitochondria isolated from control hepatocytes. Again as with
the glucagon study, the 0' mitochondria exhibited higher
glutaminase flux than the 30 minute control. Okadaic acid,
like glucagon, prevented this decrease to a large degree.
This may indicate thp. activation of phosphatase(s) during the
preincubation. This experiment lends further support for the
involvement of cytosolic phosphorylation/dephosphorylation
event(s) in the overall process of signal transduction into
the mitochondria. Such events may also contribute to the
"stable" hormonal effects seen in mitochtmdria isolated from
hormone-treated rats and hepatocytes incubated with hormones.
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Piqure ... 12. Ti.e course IIhowinq the ettecta ot hepatocyte
incUbation on sUbsequently isolated 1dtochondria
Isolated hepatocytes wel:e incubated for the indicated time in
the presence Ce) or absence (0) ot 10·1M glucaqon.
Mitochondria were isolated from these hepatocytes using the
digitonin method. Glutamina!iO. flux was dCltennined in the
Jsolated mitochondria in the presence of 20 mK glutamine and
10 DIM phosphate. Values are nmoles qlutamate formed/mg
mitochondrial protein per minute and are mean ± SEM: n-4.
*p<o.os vs no added qlucagon.
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Piql,lre 4.13. GlutUlinase J'lux in Mitochondria Iso1ated tro.
Hepatocytes - etteots ot 1 pK Okadaio Aoid
:Isolated "epatcc:,.tes were incubated for 30 minutes at J7°C in
the presence of 1 pH okadaic acid (dissolved in DMSO) or an
equiva1ent amount of DMSO, control. After 30 minutes,
mitochondria were isolated from the hepatocytes using the
digitonin method. Mitochondria were also iso1ated froll
rreshly isolated hepatocytes not exposed to the 30 minute
incubation at J7°C. These are represented as 0' incubation.
Glutaminase flux was determined in the isolated mitochondria
in the presence of 20 mM glutalline and 10 mM phosphate.
v.alues are nmoles glutamate formed/mg JlIltochondrial protein
per minute and are mean ± SEM; n=7. * p<o.os vs. 30 minute
control.
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DISCUSSION
Liver glutaminase can be influenced by hormonr.:s. This
has been previously shown in isolated hepatocytes (Joseph and
McGivan, 1978a: Covera and Garcia-Sainz, 1983; Vincent llli.....,
1989), in perfused liver (Haussinger II A.L.., 1983), and in
mitochondria from glucagon-injected rats (Lacey gj;. Al.. 1981).
The results of Figure 4.1 confirm this hormonal stimulation of
hepatic glutaminase in isolated hepatocytes. In the £:~sence
or added NH,Cl there was no stimulation or glutaminase by
either glucagon or epinephrine. In the presence of added
NH,CI, the catecholamine epinephrine and the glucogenic
hormone glucagon both stimulated "COz release. NH,C1
increased flux through glutaminase and was required for the
glucagon effect to be observed. The reason for this is unkown
and does not correspond with previous studies. In perfused
liver, Haussinger II ilL. (1983) found a stimulation of
glutaminase by glucagon in the absence of added NH,Cl, and the
effects of glucagon and NH,Cl were additive. In isolated
hepatocytes from starved rats, glucagon also stimulated
glucose production from glutamine in the absence of added
NH,CI (Joseph and McGivan, 1978a). Vincent II &.... (1989) also
found a stimUlation of glutaminase by vasopressin in the
absence of added NH,Cl.
The cytosolic protein phosphatase inhibitor okadaic acid
also increased flux through glutaminase in isolated
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hepatocytes. Okadaic acid I s only known effect is the
inhibition of protein phosphatase land 2A in the cytosol
thereby increasing the level of cytosolic protein
phosphorylation (Haystead ~ .aL.., 1989; Cohen gt AL... 1990).
Okadaic acid did not affect glutaminase flux in isolated
intact mitochondria (Table 4.1). This further indicates that
the cytosol is required for the actions of okadaic acid to
take place. The possibility still exists, however, that
okadaic acid directly prevents the dephosphorylation of an
outer mitochondrial membrane protein by a cytosolic
phosphatase. Haystead tlli..:..(19B9) incubated hepatocytes with
3ZP043' and okadaic acid to see if there was an increase in 32p_
labelling of proteins. They found a ) fold increase in
phosphorylation levels of proteins in the cytosc>lic fraction
and no increase in the microsomal fraction. In this instance
the mitochondrial fraction was not examined which is what is
needed to directly determine if okadaic acid causes an
increase in the level of mi tochondrial protein
phosphorylation. Similar studies involving the incubation of
hepatocytes with 32PO/· and glucagon have found no increase in
32p incorporation into mitochondrial membrane proteins (Siess
and wieland, 1979; Halestrap, 1986).
The results shewn in Figure 4.2 and Figure 4.) indica te
that increases in protein phosphorylation, presumably
extramitochondrial, cause
11'
increase in mltochor,drlaJ.
glutaminase flux. The results of Figure 4.11 and Figure 4.13
indicate that the hormonal signal persists in mitochondria
isolated from hepatocytes previously incubated with glucagon
or okadaic acid. Similar results have been reported for other
honones such as adrenaline, vasopressin, and angiotensin II
(Covera and Garcia-sainz, 1983). The finding that okadaic
acid produced the same effects as the hormones may indicate
that cytosolic phosphorylation/dephosphorylation events play
a role in the hormonal signalling in to the mitochondria and
may be involved in producing the stable effects seen in the
isolated mitochondria.
Protein kinase A, or cAMP-dependent protein kinase, is
responsible for the phosphorylation of many cytosolic
proteins. Such phosphorylation/dephosphorylation events play
important roles in metabolic regUlation. The previous results
obtained with the protein phosphatase inhibitors strongly
suggest that protein phosphorylation is involved in the
hormonal signal pathway to the mitochondria. Therefore, it is
possible that cAMP-induced phosphoryl.ation may also be
involved. To test this idea, the cAMP analogue cAMPS was used
in illcubations involving isolated hepatocytes. The results of
Figure 4.5 and Figure 4.6 clearly show that Sp-cAMPS, a
\)"rot.ein ~inb.s.~ ... "b.,;;';:)\\\.s..'- I ~"b.~~~~ 'b. "''b.~'1..~~ ~~~~'b.~~ ....",~
glutaminase flux in isolated hepatocytes. This Sp-cAMPS
stimulation could be inhibited by the protein kinase A
11.
antagonist, Rp-cAMPS (Figure 4.8). This indicates the
involvement of cytosolic cAMP-dependent increases in protein
phosphorylation in causing an increase in glutaminase flux
within the mitochondria.
The experiments up to this point have shown the hormonal
stimulation of glutaminase, and, in addition, have strongly
suggested the involvement of increased cytosolic protein
phosphorylation caused by the actions of a cAMP-dependent
protein kinase in stimulating the mitochondrial-located
glutaminase. From these findings it was decided to determine
the role of cAMP and cAMP-dependent phosphorylation in the
glucagon effect on liver glutaminase. To do this, the protein
kinase A antagonist, Rp-cAMPS, was used to determine if a
right-shift, or inhibition, of the glucagon curve for
glutaminase flux would occur. Such inhibition would strongly
indicate that glucagon is also stimulating glutaminase through
cytosolic, cAMP-dependent, increases in phosphorylation of
proteins. The results of Figure 4.10 indicate that no
significant inhibition by Rp-cAMPS occurred.
GLucagon may act through two plasma membrane receptors to
produce its effects. This proposal was based on studies
involving the glucagon analogue, ( l-N-a-
trinitrophenylhistidine, 12-homoarginine) glucagon (TH-
glucagon) . This analogue found to stimulate
glycogenolysis, gluconeogenesis, and urea synthesis in
115
hepatocytes without activating adenylate cyclase or causing
any increase in cAMP. It did, however, stimulate the
production of inositol phosphates (Wakelam II .!l.L.., 1986).
From this investigation they proposed the existence of two
glucagon receptors. The GR-2 receptor may be linked to
adenylate cyclase which results in an increase in cAMP, while
the GR-l receptor may be linked to inositol phospholipid
metabolism causing an increase in inositol phosphate and
ultimately in Ca2' (Wakelam II .!l.L.., 1986). In contrast, a
recent study has suggested the existence of one receptor which
may be responsible for both types of signalling (Jelinek II
ll....., 1993). This group has isolated a eDNA for a rat
functional receptor for glucagon by an expression cloning
strategy and the receptor protein has been expressed in
several kidnoy cell lines (Jelinek II Al...., 1993). They found
that when the receptor protein is expressed in the kidney cell
lines it could still bind glucagon and cause an increase in
both cAMP and intracellular calcium. Therefore although these
two studies differ with respect to the existence and number of
glucagon receptors, they do agree that glucagon causes an
increase in both cAMP and ca2'.
There are several possible explanations for the inability
of Rp-cAMPS to inhibit glucagon-stimulated glutaminase flux in
isolated hepatocytes. One possibility is that there may be
two redundant signalling pathways.
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Glucagon causes an
increase in both cAMP and ca2' in the liver. Rp-cAMPS may
inhibit the effects of increasing cAMP but the effects of
increasing Ca2' may still occur and would result in the
glucagon stimulation still being observed. The lack of
suitable apparatus for measuring intracellular calcium
prevented us from pursuing this further. A second possible
explanation is that Rp-cAMPS, which competes with endogenous
cAMP for binding to protein kinase A, may not be able to
compete with a large increase in cAMP producod by l]juc.'~gon.
In our isolated hepatocyte system, glucagon pro')".~'<'Jti its
maximal etfects at lO'7M and its half-maximal effect at lO'8M
for both glutaminase flux and glycogenolysis. Mine II iU....
(1990) have also reported a reduced sensitivity of hepatocytes
to glucagon action in batch incubation system compared to that
which is found in perfused rat liver and perifused
hepatocytes. This was attributed to the release of
unidentified inhibitor substance(s) by the hepatocytes. This
mayor may not be what is occuring in our hepatocyte system.
What is known, however, is at the effective glucagon
concentrations endogenous cAMP levels have been found to
increase up to a-fold in our hepatocyte preparation (3ois n
.aL.., 1990). Botelho n SlL. (1988) state that Rp-cAMP5 may not
be able to inhibit when glucagon is at a concentration of 10.9
M or more due to an increase in endogenous cAMP at the higher
glucagon concentrations. Therefore at a concentration of
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glucagon necessary to produce an effect on glutaminase in our
system the increase in cAMP may be too high for Rp-cAMPS to
overcome and this may result in the lack of inhibition
observed. Related to this idea is the proposal by Covera II
~ (1984) that glucagon causes a large increase in cAMP
concentration within certain intracellular compartments
whereas the protein kinase A antagonist, Rp-cAMPS, is
presumably uniformly distributed throughout the cell. Rp-
cAMPS would not be able to overcome the high concentration of
endogenous cAMP present in such compartments. Nevertheless
this remains speculative.
Figure 4.11 and figure 4.13 show that the mitochondria
isolated from fresh hepatocytes have higher glutaminase rates
than mitochondria from the incubated hepatocytes. It appears
that in the 0' mitochondria, glutaminase is somewhat
stimulated and over time this stimulation is lost in the
control incubations but is maintained in the glucagon and
okadaic acid incubations. There may be a cycle of
phosphorylation/dephosphorylation operating during the
hepatocyte incubations. Such a cycle would include the
activation of phosphatase (s). Okadaic acid may prevent the
dephosphorylation, and hence inactivation, by inhibiting the
phosphatase(s). Glucagon may cause an increase in levels of
phosphorylation thereby reducing the decrease in glutaminase
flux.
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One possible explanation for the hormonal stimulation of
glutaminase which has not been examined so far is that hormone
treatment of isolated hepatocytes results in an increase in
glutaminase protein. Such an increase would cause an increase
in glutaminase amount rather than an increase in activity of
pre-existing enzyme by the hormones. Smith and Watford (1990)
have reported that administration of dibutyryl cAMP to rats
results in a 2-fold increase in the abundance of hepatic
glutamin:....se mRNA after 5 hours. Our short term incubation of
30 minutes probably does not provide sUfficent time for
protein synthesis to occur. To test this, hepatocytes were
incubated with glucagon and with or without added
cycloheximide (0.2 mM), the eukaryotic protein synthesis
inhibitor, and glutaminase flux was determined. The results
at this experiment indicate that glucag.>n still stimulated
even in the presence of added cycloheximide (107% stimulation
by glucagon in the absence of added cycloheximide VB. 110% in
the presence of added cycloheximide).
11.
Cnanswerec:l questions
The results of this study clearly demonstrate the
involvement of protein phosphorylation and cAMP in the
signalling and activation ot glutaminase by hormones such as
glucagon. As is indicated in Figure 4.14 there are still a
number of unanswered questions as represented by the "black
box". For example, it is not known where the protein or
proteins involved ion the phosphorylation are located within
the hepatocyte, the identity of the protein(s), and whether
a cAMP-dependent protein kinase is directly involved in this
phosphorylation. If the increased phosphorylation involved in
the signalling is cytosolic, as our results seem to indicate,
then how is this increase in cytosolic protein phosphorylation
relayed to the mitochondria to affect glutaminase? Our
results with Rp-cAMPS and glucagon might suggest that, in
addition to cAMP, inositol phosphate may be involved in the
signalling process. Exactly how this occurs and how, or if,
it is related to increases in protein phosphorylation is still
uncertain.
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CHAPTER 5
SUMMARY
SUMMARY
1. streptozotocin-induced diabetes mellitus results in
increased flux through glutaminase in isolated rat
hepatocytes. This increase is prevented by maintaining
diabetic rats on daily insulin injections.
2. streptozotocin-induced diabetes mellitus results in
lncreased flux through glutaminase in isolated intact. rat
liver mitochondria. There is also an increase in glutaminase
flux at lower phosphate concentrations suggesting a left-shift
in the phosphate curve as occurs in mitochondria from
glucagon-injected rats (Lacey n!!.L.., 1981). Again, daily
insulin treatment of the diabetic rats prevents the increase
in glutaminase flux.
3. The increase in glutaminase flux in isolated intact liver
mitochondria from streptozotocin-induced diabetics cannot be
tully accounted for by the increased glutaminase activity.
This, along with the left shift of the phosphate curve, agrees
with the idea that the hyperglucagonemia associated with
diabetes is exerting an effect on glutaminase.
4. My study confirms that hepatic glutaminase is under acute
hormonal regUlation. In contrast to previous studies hormones
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were found to stimulate glutaminase in isolated hepatocytes
only in the presence of added NH,Cl.
5. Cell-permeable cytosolic protein phosphatase inhibitors
cause an increase in glutaminase flux in isolated hepatocytes.
This effect was stable, existing in mitochondria isolated from
okadaic acid-treated hepatocytes.
6. Sp-cAMPS, a prntein kinase A agonist, causes an increase
in glutaminase flux in isolated hepatocytes. This increase
can be inhibited by the protein kinase A antagonist, Rp-cAMPS.
Thus increases in cytosolic protein phosphorylation levels,
probably through a cAMP-dependent protein kinase, ca., cause an
increase in glutaminase flux within the mitochondria.
7. In isolated hepatocytes, increases in glutaminase flux
caused by the addition of glucagon were not inhibited by the
protein kinase A antagonist, Rp-cAMPS. This indicates that
the signalling mechanism involved in transmitting the glucagon
signal into the mitochoneria is more complex and may involve
more than just an increase in cAMP ane protein phosphorylation
levels. More investigation is needed in this ar~il.
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